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ABSTRACT

MECHANISMS OF CALCIUM BUFFERING AND AGING IN NEURONS:
TESTING THE LIMITS OF HOMEOSTASIS

by

William James Pottorf, II
Doctor of Philosophy, Graduate Program in Pharmacology
Loma Linda University, September 2000
Dr. John N. Buchholz, Chairperson
•
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Intracellular calcium ([Ca ]i) is an ubiquitous second messenger that integrates
multiple and diverse neuronal pathways that include development and maturation, gene
expression, synaptic plasticity, transmitter release, excitability, and even cell death.
Upon neuronal excitation the [Ca ]i increases rapidly and the calcium buffering system
reacts quickly to restore [Ca2T" ]i to basal levels in order to reset the cell for the next
stimulus and avoid prolonged exposure to cytotoxic levels of high [Ca ]i. The aging
process appears to causes multiple changes in the ability of neurons to regulate [Ca ]i
homeostasis and an age-related breakdown in the mechanisms controlling [Ca2+]i
homeostasis could contribute to decreased neuronal function or neurodegeneration. Thus,
it is hypothesized that the aging process results in decreased function of
sarco/endoplasmic reticulum calcium ATPase (SERCA) pumps, leading to greater or
more sustained [Ca2+]i levels, an increased reliance on remaining calcium buffering
components to restore [Ca2+]i homeostasis and regulate neurotransmitter release in
adrenergic neurons.
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CHAPTER I

INTRODUCTION AND REVIEW OF CALCIUM BUFFERING MECHANISMS AND
AGING IN ADRENERGIC NEURONS

William J. Pottorf i
Sue P. Duckies 2
John N. Buchholz

i

i

Department of Physiology & Pharmacology, Loma Linda University

Department of Pharmacology, College of Medicine, University of California, Irvine

Journal of Autonomic Pharmacology in press (2000)

1

1.

INTRODUCTION
2+ . .

Intracellular calcium ([Ca ]i) is a universal second messenger integrating
numerous cellular pathways. These include neuronal development and maturation, gene
expression, synaptic plasticity, transmitter release, excitability, and cell death (Choi,
1992; Berridge, 1995, 1998; Clapham, 1995; Ginty, 1997; Malenka, Dauer, Perkel &
Nicoll, 1989; Spitzer & Ribera, 1998). Mechanisms regulating [Ca2+]i allow an
9-4-

enormous calcium gradient across neuronal membranes with resting [Ca ]i levels at 100200 nM compared to extracellular calcium concentration of approximately 1 mM
(Meldolesi, Huttner, Tsien & Pozzan, 1984; Nachshen, 1985; Ashley, 1986). Cellular
excitation induces [Ca2+]i-transients ranging from sub-micromolar to several micromolar,
necessitating cellular mechanisms to rapidly return [Ca ]i to resting levels (Nachshen,
1985; Fontana & Blaustein, 1993; Ghosh & Greenberg, 1995). Therefore it is not
surprising that neurons contain intricate systems for regulating [Ca ]i. Intracellular
calcium buffering systems include calcium binding proteins, plasma membrane extrusion,
and sequestration into intracellular organelles. In a concerted fashion these diverse
calcium buffering systems attenuate [Ca ]i-transients and maintain resting [Ca ]i levels.
The aging process is thought to cause multiple changes in the ability of central
and peripheral neurons to regulate [Ca2+]i homeostasis (Duckies, Tsai & Buchholz, 1995;
Michaelis et al., 1996; Murchison & Griffith, 1999). This is particularly important in the
case of neurons, which have been shown to be highly vulnerable to calcium overload
(Choi, 1994, 1995). The pervasive involvement of calcium in multiple neuronal
9-4-

pathways suggests that age-related alterations in the function of [Ca ]i homeostasis
could contribute to age-related neuronal degeneration (Gibson & Peterson, 1987;
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Khachaturian, 1994; Thibault et al, 1998). Numerous studies link dysregulation of
[Ca2+]i homeostasis to [Ca2+]i-dependent neurotoxicity and cell death in the pathological
condition of Alzheimer’s disease (Mattson et al, 1993a; Thibault et al, 1998; Chen &
Fernandez, 1999). In addition to neurodegeneration, altered [Ca2+]i homeostasis has also
been linked to age-related changes in norepinephrine (NE) release from adrenergic nerve
endings (Buchholz & Duckies, 1990; Tsai, Pottorf, Buchholz & Duckies, 1998; Mattson,
Rydel, Lieberburg & Smith-Swintosky, 1993b), and this could contribute to development
of hypertension and increased risk of stroke. Disruption of calcium homeostasis could
account for numerous cellular pathologies and cell death associated with aging, concepts
that deserve further exploration.
There is considerable knowledge of the mechanisms involved in regulating
2+

neuronal [Ca ]i and neurotransmitter release. Despite this knowledge the importance
and participation of individual calcium buffering components and the impact of age on
their function is not sufficiently understood. This dissertation examines the evidence for
age-related alterations in neuronal calcium buffering and changes in the control of
neurotransmitter release in the autonomic nervous system. Most of the knowledge
concerning neuronal calcium regulatory systems is derived from studies of the central
nervous system with only limited number addressing autonomic nerves. Therefore, the
limited work in autonomic nerves will be emphasized, but supporting studies of the
central nervous system will be discussed where gaps remain to be filled.

3

2.

REGULATION OF INTRACELLULAR CALCIUM IN NEURONS
Calcium homeostasis in neurons involves several calcium buffering components

working in concert to restore stimulation-evoked [Ca2+]i-signals to basal levels (for
review see Kostyuk & Verkhratsky, 1994). Calcium influx occurs via plasmalemmal
voltage-gated and ligand-gated calcium channels and/or calcium release from
endoplasmic reticulum (ER) stores via inositol-1,4,5-triphosphate receptors (IP3R) and
calcium-induced, calcium release (CICR), mediated by ryanodine receptors. In neurons,
•

o I

stimulation-evoked increase in [Ca ]i leads to activation of the neurotransmitter release
mechanism, consequently inactivation of neurotransmitter release is in part regulated by
calcium buffering mechanisms. These include calcium sequestration into ER by
sarco/endoplasmic reticulum Ca -ATPase (SERCA) pumps, mitochondrial calcium
uptake, cytosolic calcium binding proteins, plasmalemmal calcium extrusion via plasma
membrane Ca2+-ATPase (PMCA) pumps, and Na+/Ca2+-exchange. Each of these calcium
regulatory systems is illustrated in Figure 1 and will be briefly discussed below.

4

3.
3.1

CALCIUM INFLUX AND INTRACELLULAR RELEASE
Plasmalemmal Calcium Channels
Neuronal cells express multiple types of plasmalemmal calcium channels that can

be activated by various excitatory stimuli. The two main families of plasmalemmal
calcium channels include voltage-gated calcium channels (T-, L-, N-, P-, Q-, R) and
ligand-gated calcium channels (including acetylcholine, glutamate, and ATP-activated
channels) (Kostyuk, 1989; Miller, 1992; Lundy & Frew, 1996; Bean, Williams & Ceelen,
1990; Trouslard, Marsh & Brown, 1993; Bumashev, Zhou, Neher & Sakmann, 1995).
The selectivity of the calcium channels results in a typical “calcium current” as these ions
enter the cytosol and generate a calcium signal (Kostyuk, Mironiv & Shuba, 1983; Kim,
Morii, Sun, Imoto & Mori, 1993).

3.2

Calcium Release from ER Stores
It is increasingly evident that [Ca2+]i storage sites, like the ER, also play a crucial

role in providing calcium for regulating and maintaining complex calcium signals and
cellular functions such as excitability, neurotransmitter release, gene expression, and
even apoptosis (Berridge, 1993; Hardingham, Cruzalegui, Chawla & Bading, 1998;
Mattson, Guo, Furukawa & Pedersen, 1998; Verkhratsky & Petersen, 1998; Li, Miyata &
Hatton, 1999). There are at least two distinct ER calcium stores, each of which is
controlled by a functionally distinct second messenger. The IP3R is activated by the
intracellular second messenger IP3 (for review see Berridge, 1993), while CICR is
initiated by the rise in [Ca ]i. Calcium ions themselves and ADP-ribose control the
sensitivity of the CICR channel to calcium (Usachev & Thayer, 1997).

6

4.

CALCIUM BUFFERING SYSTEMS

4.1

Intracellular Calcium Binding Proteins
Intracellular calcium binding proteins are mobile proteins belonging to the EF-

hand family with the helix-loop-helix conformation. These calcium buffering proteins
include parvalbumin, calmodulin, calretinin, calcineurin, and calbindin-D28k (for review
see Heizmann & Hunziker, 1991). These binding proteins, along with ATP-Ca
complexes, have an enormous capacity to buffer calcium ions. Collectively, these mobile
buffers adsorb nearly 95-99% of the total cellular calcium load, leaving the rest available
as free calcium ions (Belan, Kostyuk, Snitsarev & Tepikin, 1993). The mobile calcium
buffer proteins are important for the facilitated transcellular diffusion of calcium ions and
the propagation of calcium signals within the cell cytoplasm (Chard, Bleakman,
Christakos, Fullmer & Miller, 1993).

4.2

ATP-Dependent Calcium Pumps
Two families of P-type Ca2+-ATPase pumps are vital for the regulation of [Ca2+]i-

transients: PMC As that extrude calcium from the cytosol to the extracellular space
(Werth, Usachev & Thayer, 1996; Carafoli, 1997) and SERCAs that sequester calcium
from the cytosol into the ER lumen (Michaelis, Michaelis, Chang & Kitos, 1983; Inesi &
Kirtley, 1992; Tsai et al., 1998). PMCAs utilize ATP hydrolysis to remove calcium from
the cytosol with a 1:1 ratio (Niggli, Adunyah, Penniston & Carafoli, 1981). In contrast,
SERCAs sequester two calcium ions for each ATP molecule used (MacLennan, 1970).
PMCAs are expressed as multiple isoforms from four different genes (PMCA1,2,3,4),
while SERCAs are expressed by three distinct genes (SERCA1,2,3), and each gene

7

transcript is able to generate alternative splice variants (Wuytack et al., 1992).
Expression of these Ca2+-ATPase pumps is interdependent and is co-expressed in a
tissue-specific manner (Liu, Xu, Fridman, Muallem & Kuo, 1996). In addition, Ca ATPase pump expression can be regulated by hormones, growth factors, and [Ca ]i
(Simonides et al, 1996; Kuo et al, 1997; Tajima et al, 1998). Although all these
calcium pumps belong to the same family, they show considerable diversity in structure,
function, and pharmacology (Lytton, Westlin, Burk, Shull & MacLennan, 1992; Kuo et
al, 1997). For a more detailed description of the ATP reaction cycle and molecular
structure of SERCAs, please refer to Appendix I (page 192).

4.3

Mitochondrial Calcium Uptake and Storage
Mitochondria display a robust capacity to sequester small and large calcium loads.

Early studies suggested that mitochondria only buffer calcium under non-physiological
conditions, such as when [Ca2+]i exceeds 2 pM (Nicholls, 1985), as in some pathological
states (Wilson, Arnold, Burke & Schrier, 1984; Khandoudi, James & Feuvray, 1989).
Recently mitochondria have been established as an important participant in the control of
[Ca2+]i-transients and have been shown to buffer [Ca2+]i loads within normal
physiological ranges and in the absence of pathology (Werth & Thayer, 1994; Buchholz,
Tsai, Foucart & Duckies, 1996; David, Barrett & Barrett, 1998; Pinton et al, 1998;
Rizzuto et al, 1998). Calcium uptake by the mitochondria occurs by a H /Ca uniporter, which is driven by the mitochondrial membrane potential established by the
electron transport chain (Thayer & Miller, 1990). The mitochondrial uniporter is a high
capacity system that can transport large as well as small calcium loads.
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4.4

I

2

Plasmalemmal Na /Ca -Exchanger
_l_

2+

The Na /Ca -exchanger is found in the plasma membrane of a variety of
excitable and non-excitable cells and uses the energy of the sodium electrochemical
gradient to expel one calcium ion for every three sodium ions brought into the cell
(Blaustein & Lederer, 1999). The Km of the exchanger is approximately 2 pM; therefore,
it is thought that the exchanger is primarily responsible for regulating large calcium loads
and less important in adjusting small calcium loads and resting [Ca2+]i levels (Reeves &
Sutko, 1979; Werth et al, 1996).

5.

AGE-RELATED ALTERATIONS IN THE CONTROL OF
NEUROTRANSMITTER RELEASE
There are numerous studies showing an age-related rise in systemic blood

pressure is accompanied by increased levels of plasma catecholamines (Palmer, Zeigler
& Lake, 1978; Esler et al, 1981; Barnes, Rashkind, Gumbrecht & Halter, 1982; Insel,
1993). In support of this idea, activity of tyrosine hydroxylase, the rate limiting step in
NE and epinephrine synthesis, and levels of mRNA have been shown to increase with
age in the adrenal medulla of F-344 rats (Turner, Hale, Lawler & Strong, 1992). Elevated
plasma catecholamines, especially NE, have been used as an index of increased
sympathetic nerve activity occurring with age (Nishimura et al, 1979). Thus, these data
point to the possibility that peripheral vascular adrenergic nerve activity may actually
increase with age.
As an extension of this concept that adrenergic nerve activity actually increases
with age, in arteries studied in vitro, including the rat tail artery and superior mesenteric
artery, stimulation-evoked fractional NE release has been shown to increase with age
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(Buchholz & Duckies, 1990; Buchholz, Sexton & Hewitt, 1998). Furthermore, in the rat
tail artery this age-related increase in NE release occurs over a wide range of stimulation
frequencies from 0.25 to 8 Hz (Tsai, Duckies & Buchholz, 1995). These age-related
increases in plasma catecholamines and peripheral adrenergic nerve activity, could
contribute to increased incidence of cardiovascular disorders including coronary artery
disease, heart failure, and hypertension.
There are a number of possible explanations for an age-related increase in NE
release from adrenergic nerves. Age-related alterations in nerve density, neurotransmitter
content and re-uptake, prejunctional cc2-adrenergic receptors, and calcium regulation are
possible sites of dysfunction that could lead to increased neurotransmitter overflow
(Duckies, Carter & Williams, 1985; Handa & Duckies, 1987; Buchholz & Duckies, 1990;
Buchholz, Tsai, Friedman & Duckies, 1992; Duckies et al, 1995; Buchholz et al., 1996).
Elucidation of the etiology of age-related changes in cardiovascular function requires an
understanding of the mechanisms controlling neurotransmitter release and how the
regulation of adrenergic nerve function may change with age.

5.1

Neurotransmitter Content and Adrenergic Nerve Density
Norepinephrine content in the rat heart is reported to decrease with age (Martinez

et al, 1981; Dawson & Meldrum, 1992). In rat blood vessels the consensus is less
straightforward, with reports of increased neurotransmitter content (renal, femoral and
saphenous arteries), no change (renal, femoral, saphenous and superior mesenteric veins),
or a decrease (tail arteries) with advancing age (Handa & Duckies, 1987). Catecholamine
histofluorescence, as a measure of adrenergic nerve density, has been shown to increase
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with advancing age in rat superior mesenteric artery, renal artery, and portal vein (Mione,
Erdo, Kiss, Ricci & Amenta, 1988). In contrast, density of adrenergic innervation of
spinal cord blood vessels showed no age-related change (Amenta, Bronzetti, Ferrante &
Ricci, 1990). Thus the impact of age on adrenergic nerve density appears to depend on
the model and methodology utilized, so that no clear conclusion about advancing age and
adrenergic nerve function can be drawn from studying adrenergic nerve density in
isolation.

5.2

Transmitter Uptake in Adrenergic Nerves
The function of neuronal neurotransmitter reuptake mechanisms is to reduce

levels of neurotransmitter in the neuroeffector junction and minimize spillover into the
circulatory system (Esler et al, 1995). Using the selective blockers, cocaine and
deoxycorticosterone, the impact of age on the contribution to NE uptake by adrenergic
neuronal and extraneuronal systems, respectively, can be assessed. Effects of these
blockers of uptake have been shown to be reduced with age in pithed rat and isolated rat
atria (Borton & Docherty, 1989) and vas deferens (de Avellar, Kobashi & Markus, 1990),
suggesting that NE uptake declines with advancing age. In contrast in rat heart (Limas,
1975) and rat tail artery (Buchholz & Duckies, 1990), the effect of cocaine and
deoxycorticosterone on NE uptake was shown to increase with advancing age. However,
in rat tail arteries when NE release due to blocked uptake was corrected for the total
amount of NE release in absence of drugs, no change with age was observed (Buchholz
& Duckies, 1990). Thus age-related alterations in the effect of uptake antagonists on NE
release are not necessarily due to changes in the function of the NE transporters per se.
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Rather age-related changes in the effect of these blockers may be due more to changes in
the biophase concentration of NE in the junctional cleft. Thus, this approach suggests
that with advancing age, the amount of NE taken up remains a constant fraction of the
amount of NE released.
Direct measurement of the accumulation of [3H]-NE as an index of uptake and
storage showed no age-related change in femoral or renal arteries or renal veins of rats
(Duckies et al, 1985). From both of these approaches, direct measurement of NE uptake
or assessment of the effect of uptake blockers, there is no support for an age-related
change in the function of NE uptake systems. Thus, the observed increase with age in
stimulation-evoked fractional NE release cannot be explained by an age-related decline in
the function of NE transporters.

5.3

Function ofPrejunctional a2-Adrenergic Receptors
Prejunctional ot2-adrenergic receptors mediate a negative feedback response

whereby released NE modulates its own further release (for reviews see Hies, 1986;
Danger & Arbilla, 1990). Direct measurements of NE overflow have shown an agerelated decrease in effectiveness of prejunctional cci-adrenergic receptor blockade in
pithed rats (Docherty & Hyland, 1986), isolated rat vas deferens (Hyland & Docherty,
1985), rat heart (Daly, Goldberg & Roberts, 1989), and rat tail artery (Buchholz &
Duckies, 1990; Buchholz et al, 1992).
Superficially, these studies support the concept of a general age-related decline in
the function of prejunctional ai-adrenergic receptors. However, although there was an
age-related decline in sensitivity of prejunctional ai-adrenergic receptors to the
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antagonist idazoxan, closer observation revealed no age-related difference in the maximal
response to this drug (Buchholz et al, 1992). It is logical to assume that an age-related
increase in NE release would lead to greater biophase concentrations of NE. This would
result in more NE bound to the ot2-adrenergic receptor and greater competition between
higher levels of NE and a given antagonist concentration, resulting in apparent reduced
sensitivity to the applied antagonist. Thus, the observed shift in potency of a2-adrenergic
antagonists with age may merely reflect greater competition with increased levels of
endogenous NE.
In light of the studies summarized above, age-related changes in NE release
cannot be explained by changes in the function of NE uptake mechanisms or ot2adrenergic receptors. Other possibilities are that age-related changes in adrenergic
transmitter release may be a consequence of alterations in calcium influx and/or efflux
from intracellular calcium stores, intracellular buffering, or the sensitivity of the release
mechanism. One approach to determining whether any of these factors might contribute
to the age-related increase in NE release would be to determine whether there is any agerelated change in sensitivity of stimulation-evoked transmitter release to variations in
extracellular calcium.

5.4

Effects ofAltering Extracellular Calcium Concentration
The effects of altering extracellular calcium on stimulation-evoked NE release

were compared in tail arteries from young and old rats (Buchholz, Nikkah & Duckies,
1994). Stimulation-evoked NE release from adrenergic nerves of the tail artery from old
rats was found to be more sensitive to an increase and less sensitive to a decrease in
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extracellular calcium compared to nerves in tail arteries from young animals. Several
possible explanations could account for this age-related difference in calcium sensitivity.
First, it has been shown in rat hippocampal pyramidal neurons that calcium dependent
potassium afterhyperpolarizations, calcium spike duration, and calcium current through
calcium channels are all elevated with age (Landfield & Pitler, 1984; Pitler & handheld,
1990). These data suggest that calcium channel function may be altered with age
resulting in increased calcium influx into neurons. Second, the function of neuronal
calcium buffering and extrusion mechanisms (e.g. calcium binding proteins, PMCA,
Na /Ca -exchanger, SERCA and mitochondria) has been suggested to decline with
advancing age in both central and peripheral neurons (de Jong et al, 1996; Michaelis et
al., 1996; Pottorf et al., 2000; Satrustegui, Villalba, Pereira, Bogonez & MartinezSerrano, 1996). A decline in buffering and/or extrusion could possibly result in greater or
more prolonged [Ca ]i, leading to increased transmitter release. Third, the function of
the release mechanism that is sensitive to calcium and responsible for vesicle
mobilization during neurotransmitter release has been suggested to alter with age in rat
adrenergic nerves (Parfitt, Hoffer & Browning, 1991). Thus there are multiple regulatory
targets in adrenergic neurons whose function could be affected by the aging process.

5.5

Role of Calcium Influx
The contribution of calcium influx has been measured in several regions of the

nervous system by both current-clamp and voltage-clamp methods. Calcium currents
have been reported to increase (Landfield & Pitler, 1984), decrease (Kostyuk, Pronchuk,
Savchenko & Verkhratsky, 1993), or remain unchanged (Murchison & Griffith, 1996)
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with advancing age. To determine whether function of neuronal calcium channels is
essential to age-related changes in NE release in the rat tail artery, calcium channels were
bypassed using the calcium ionophore, ionomycin, to initiate calcium influx and NE
release. However, ionomycin-induced NE release remained greater in adrenergic nerves
of tail arteries from old as compared to young rats (Tsai, Hewitt, Buchholz & Duckies,
1997). Thus, despite the studies in central neurons suggesting that calcium influx may
increase with age, this alone does not fully explain the age-related increase in NE release
from peripheral adrenergic nerves.

5.6

Effects ofIncreasing Calcium Buffering Capacity
To test whether the capacity of calcium buffering declines with age an artificial

buffer was used. The intracellular calcium chelator bis(2-aminophenoxy)ethaneN,N,N’,7V’-tetraacetic acid (BAPTA) was applied to rat tail arteries, and stimulationevoked NE release was measured. Addition of BAPTA was more effective at reducing
stimulation-evoked NE release in older rat tail arteries compared to arteries from young
animals (Tsai et al, 1997). These data suggest that there is an age-related reduction in
calcium buffering capacity.

5.7

Sensitivity ofNorepinephrine Release Mechanism
Calcium influx and intracellular buffering only, in part, regulate the control of NE

release from nerve endings. Mechanisms exist which can “sensitize” the release
mechanism to a given stimulation-evoked [Ca2+]i-transient (Trifaro & Vitale, 1993).
Phosphorylation of synapsins by phorbol esters can potentiate NE release by increasing
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the number of vesicles that can be mobilized and released in response to a given [Ca ]isignal (Kotsonis & Majewski, 1996). Thus, observations discussed above showing an
age-related increase in the sensitivity of adrenergic nerves to increased extracellular
calcium could also be related to changes in the sensitivity of the release mechanism to
calcium. There are no clear studies exploring the effect of advancing age on the
sensitivity of the transmitter release mechanism itself. Thus, at this time it is difficult to
come to any conclusion concerning the possible impact of age on function of the
transmitter release mechanism.

6.

SUMMARY: EFFECTS OF AGING ON CONTROL OF
NEUROTRANSMITTER RELEASE
Clearly current knowledge of the consequence of aging on mechanisms

controlling NE release from peripheral adrenergic nerves is limited. Nevertheless,
several key points can be made concerning the impact of age on adrenergic nerve
function. As discussed above, an age-related increase in stimulation-evoked NE release
from adrenergic nerves has been observed in the rat model. It appears that
neurotransmitter re-uptake remains constant with advancing age, or at least the amount of
transmitter re-uptake remains a constant fraction of the amount of NE released from the
nerve terminal. Secondly, the function of prejunctional cc2-adrenergic receptors also
appears to be maintained with age when competition between antagonist and the greater
biophase concentration of NE is taken into consideration. Third, adrenergic nerves show
a greater sensitivity to alterations in extracellular calcium with age. These data could be
explained by any one or a combination of changes in calcium influx, buffering, or
sensitivity of the release mechanism to calcium. In the particular studies discussed
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above, bypassing calcium channels and the increased effect of an artificial buffer on NE
release have led to a focus on calcium buffering mechanisms. Despite this focus on
calcium buffering, the possibility that there are age-related changes in calcium influx or
sensitivity of the NE release mechanism to calcium has not been ruled out and remains a
subject for future investigation.

7.

EFFECT OF AGE ON NEURONAL CALCIUM HOMEOSTASIS
Each component of the intracellular calcium buffering system functions in

regulating stimulation-evoked calcium signals (Fig. 1). Therefore, impairment of any one
component has the potential to affect [Ca2+]i homeostasis. However, the existence of
multiple calcium buffering components also allows for compensation by one for the
decreased function of another. The focus of the discussion below will be on the impact
of age on the function of SERCA calcium pumps, mitochondrial calcium uptake and
plasmalemma calcium extrusion systems.

7.1

Function of SERCAs
One factor in calcium dysregulation with age appears to be a decline in the

function of SERCAs. An age-related decline in transport of calcium by SERCA pumps
has been demonstrated in the cerebral cortex. This was measured after intravenous
infusion of 45Ca2+ into mice followed by fractionation of cortical SER. Uptake of 45Ca2+
into the SER was found to decline by 50% in cortex from old as compared to young mice
(Gibson, Perrino & Dienel, 1986). Studies in autonomic nerves using the selective
blockers thapsigargin and cyclopiazonic acid have revealed similar age-related declines

17

in the function of SERCAs (Tsai et al., 1998). In isolated rat superior cervical ganglion
(SCG) cells, microfluorometric measurements of [K+]-evoked [Ca2+]i-transients in the
presence of these SERCA blockers showed a significant decline in the rate of calcium
recovery in young SCG cells but no significant change in calcium recovery in old cells.
Further evidence of an age-related change in SERCA function was observed when NE
release was measured in the presence of the same SERCA blockers, showing an increase
in stimulation-evoked NE release in young rat tail arteries with no change in arteries from
old animals (Tsai et al., 1998).
One explanation for such a decline in SERCA function with age may be changes
in expression of SERCA isoforms. Indeed, SERCA mRNA expression declines with age
in cardiac tissue and vascular smooth muscle (Maciel, Polikar, Rohrer, Popovich &
Dillmann, 1990; Lompre, 1999). Conversely, changes in mRNA expression did not
correlate with levels of SERCA proteins in rat skeletal muscle and myocardium, which
were shown to remain stable with advancing age (Ferrington et al., 1997; Xu &
Narayanan, 1998). However, despite unchanged SERCA content, calmodulin mediated
activation of 45Ca2+-uptake declined with age, corresponding to a decline in calmodulin
mediated phosphorylation of SERCAs (Xu & Narayanan, 1998). Further studies are
necessary to determine the mechanism by which function of SERCAs may be influenced
by age. These might include a determination of the impact of age on fluidity of SER
membranes, and how these changes, if any, may influence the function of these integral
membrane proteins.
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7.2

Mitochondrial Calcium Uptake
Studies of rat hippocampal neurons have suggested that age-related alterations in

calcium homeostasis are due to a decline in mitochondrial calcium uptake (Vitorica &
Satrustegui, 1986; Villalba, Pereira, Martinez-Serrano & Satrustegui, 1995; Satrustegui et
al., 1996). The energy required for calcium uptake by the mitochondria is generated by
maintenance of the mitochondrial proton gradient, providing the electrochemical
potential to drive the H+/Ca2+-uniporter (Nicholls, 1985; Gunter & Pfeiffer, 1990).
However, in rat liver microsomes and brain synaptosomes there is no significant agerelated change in the mitochondrial proton gradient, respiratory rate, or membrane
potential (Vitorica, Clark, Machado & Satrustegui, 1985; Paradies & Ruggiero, 1991).
Therefore, if the mitochondrial proton gradient is maintained with advancing age one
might also predict that the calcium buffering capacity of the mitochondria would be
preserved. In recent studies, the presence of high concentrations of vanadate, which
block both PMCAs and SERCAs, together with replacement of sodium with
tetraethylammonium to block the Na /Ca -exchanger, essentially forced adrenergic
2+

neurons to rely on mitochondria to regulate [Ca ]i-transients. Under these conditions the
capacity for calcium uptake by mitochondria did not significantly change with age
(Pottorf et al, 2000). Thus when multiple calcium buffering systems are blocked,
mitochondria are still able to restore [Ca ]i-transients to basal levels in adrenergic
nerves, and this ability is maintained in nerves from older animals.
Increased reliance on mitochondrial calcium uptake in SCG cells from older
animals has also been demonstrated. When SCG cells were exposed to the mitochondrial
calcium uptake blocker, dinitrophenol (DNP), peak [K ]-induced [Ca ]i-transients and
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rate of rise of [Ca2+]i increased in cells from aged animals, but there was no significant
effect of DNP in SCG cells from young animals (Buchholz et al., 1996). Similarly,
exposure of tail arteries from aged animals to DNP resulted in increased stimulationevoked NE release with no significant effect of DNP in young arteries (Tsai et al., 1995).
Studies in rat pyramidal neurons have also shown that when SERCA calcium uptake is
blocked mitochondria can compensate and effectively buffer [Ca ]i-transients (Fion &
Mugnaini, 1981). Other studies in rat basal forebrain neurons from old animals showed
that mitochondria are able to compensate for an age-related increase in calcium influx
(Murchison & Griffith, 1998). Together these studies suggest that mitochondrial calcium
uptake in peripheral and central neurons may become more important functionally with
advancing age.

7.3

Plasma Membrane Calcium Transport Systems
It is plausible to assume that additional components of the calcium buffering

system, other than mitochondria, may also compensate for a decline in calcium regulation
with advancing age. Recent evidence has highlighted the role of the PMCAs as
important participants in the dynamic regulation of [Ca2+]i-transients and as crucial
players in calcium extrusion during normal (Carafoli & Stauffer, 1994; Werth et al,
1996) and pathological conditions (Garcia & Strehler, 1999). Additionally, Na+/Ca2+exchange is a crucial component of [Ca2+]i regulation that interconnects both sodium and
calcium homeostasis in neuronal cells (Blaustein & Lederer, 1999).
Alterations in calcium homeostasis due to blockade of SERCAs with thapsigargin
have been shown to result in an induction of PMCA expression as measured by gene
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transcription (mRNA expression) in rat aortic endothelial cells (Kuo et al, 1997). In
failing myocardium, there is an increased dependence upon Na+/Ca2+-exchange when the
function of SERCAs declines (Hasenfuss et al, 1999). In rat adrenergic neurons, when
mitochondrial calcium uptake and SERCAs are blocked with DNP and thapsigargin,
respectively, SCG cells are “forced” to rely on plasma membrane calcium extrusion
systems (PMCAs and Na+/Ca2+-exchangers) to control high [K+]-evoked [Ca2+]itransients. Under these conditions SCG cells from both old and young animals were able
to fully recover from high [K ]-evoked [Ca ]i-transients. These data suggest that
plasmalemmal calcium extrusion can by itself control [Ca2+]i-transients, and there is no
age related change in the function of these systems in SCG cells (Tsai et al, 1998). In
contrast to these results in rat SCG cells, however, the function of PMCAs in rat brain
synaptosomes has been shown to progressively decrease with advancing age (Qin et al.
1998). Furthermore, activation of PMCA mediated calcium uptake by the cofactor
calmodulin has been shown to decline with advancing age in the rat brain (Michaelis et
al, 1996; Gao, Yin, Yao, Williams & Squier, 1998).
The ability of Ca2+-ATPase pumps in plasma membranes and ER to control [K+]evoked [Ca2+]i-transients was also assessed with advancing age in SCG cells. Blockade
of PMCA function with a relatively low concentration of vanadate (0.25 pM), which does
not significantly affect the function of SERCAs, induced a greater decline in the rate of
recovery of [Ca2+]i in SCG cells from old compared to young animals (Pottorf et al.
2000). Increasing the vanadate concentration to 1.0 pM, which can block both PMCAs
and SERCAs, did not significantly alter the rate of recovery of [Ca2+]i in old SCG cells;
however, there was a further decline in calcium recovery in cells from young animals
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(Pottorf et al., 2000). These data suggest that PMCA function is maintained with age;
furthermore, the plasma membrane extrusion system can apparently provide some
compensatory buffering capacity for the age-related deficiency in SERCA function.
However, even though PMCA function may decline with age in some neuronal models,
this does not invalidate the possibility of compensation by additional calcium buffering
components as we have observed in our SCO cells from aged animals. Studies in SCO
cells suggest that the calcium buffering systems have several redundant mechanisms that
allow for compensation when one or more components are compromised. Therefore,
with advancing age the remaining calcium buffering components become a critical part of
maintaining calcium homeostasis and preventing calcium overload in neurons.

8.

8.1

HYPOTHESIS FOR AGE-RELATED CHANGES IN NEURONAL CALCIUM
REGULATION
Hypothesis 1: Permanent Changes in Neuronal Calcium Regulation
Several current hypotheses have attempted to explain the relationship of aging to

observed declines in neuronal function. One hypothesis postulates that age-related
alterations in neuronal calcium homeostasis result in a permanent change in the
9-1-

regulation of [Ca ]i leading to neurodegeneration (Khachaturian, 1994). While studies
have documented the neurotoxic effect of calcium overload in initiating neuronal death
(Choi, 1994), this may not be the case in the normal physiological process of aging. For
instance, Alzheimer’s disease is marked by a loss in hippocampal neurons (Jellinger,
1998); however, other studies examining normal aging have shown that the number of
neurons is preserved in the dentate gyrus and CA1 pyramidal regions of the hippocampus
(West, Coleman, Flood & Troncoso, 1994; Calhoun et al, 1998). Thus, the hypothesis of
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[Ca ]i dysfunction and neuronal loss may apply more to pathological conditions than to
the process of normal neuronal aging.

8.2

Hypothesis 2: Subtle Changes in Neuronal Calcium Regulation
Another hypothesis is that the progression of aging induces a subtle change in
9-1-

[Ca ]i homeostasis leading to impaired neuronal performance rather than neuronal loss.
In theory, subtle changes in any component of the calcium buffering system could lead to
dysregulation of calcium homeostasis and altered neurotransmitter release. In support of
this hypothesis are data demonstrating the impact of age on NE release. As discussed,
age-related increases in stimulation-evoked NE release from rat vascular adrenergic
nerves cannot be accounted for by changes in NE content, the function of neuronal or
extraneuronal uptake mechanisms, or the function of prejunctional ot2-adrenergic
receptors (Buchholz & Duckies, 1990; Buchholz et al, 1992). In addition, the SERCA
antagonist cyclopiazonic acid elevated stimulation-evoked NE release only in adrenergic
nerve endings from young animals (Tsai et al, 1998). Taken together these studies
measuring NE release from adrenergic nerve endings suggest that the link between aging
and increases in NE release may consist of subtle alterations in the function of SERCAs
in nerve endings thus altering [Ca ]i homeostasis. In support of this idea, measurement
of [Ca2+]i-transients in SCO cells by microfluorometry reveal an age-related decline in
ATP-dependent Ca2+-uptake by SERCAs (Tsai et al, 1998; Pottorf et al, 2000). As a
consequence of decreased SERCA function, neurons from older animals become more
reliant on mitochondria to control [Ca2+]i compared to young (Tsai et al, 1995; Buchholz
et al, 1996).
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8.3

Governing Hypothesis
In adrenergic nerves from old animals, calcium uptake by ATP-dependent

calcium buffering systems is reduced, leading to greater or more sustained neuronal
2_|_

[Ca ]i levels, a greater reliance on remaining calcium buffering systems to restore
[Ca ]i homeostasis and increased neurotransmitter release (Fig. 2A,B).
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Figure 2. Representation of the hypothesized age induced alteration in calcium buffering
systems. In theory, alterations in one component of the calcium buffering system could lead to
dysregulation of calcium homeostasis and increased neurotransmitter release. (A) In young
neuronal cells, all components of the calcium buffering systems are working within normal limits
(illustrated by thin, black arrows) and together regulate neurotransmitter (NT) release. (B)
However, with advancing age the function of the sarco/endoplasmic reticulum calcium ATPase
(SERCA) buffering component is reduced, leading to increased neurotransmitter release.
Because of this deficit there is a shift towards dependence on the remaining calcium buffering
components (illustrated by thick, black arrows) to prevent calcium overload, regulate NT release,
and maintain calcium homeostasis. The red dotted arrow represents a decline in calcium uptake
by SERCAs, while the large red arrow represents induction of NT release by calcium. The green
dotted arrows represent calcium buffering pathways that attenuate increases in [Ca2+]i and bring
[Ca2+]i back to basal levels.

25

A. Young Neuronal Cell:

Normal Functioning Calcium Buffering Systems
Smooth Endoplasmic Reticulum
Ca2+

PMCA
Ca2+ -(»)

Ca2+

SERCA
)—►

A

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

*•. ••

Ca2+

Mitochondria

Ca2+

< IU',:

Ca2+

H+

Ca2+ H+ H+

Na+

H+

Calcium Binding
Proteins
^Ca2+
Ca2+^ Ca2+
Ca2+.

NT vesicle
release

H+

H+

Ca2+
H+

H+

H+

Ca2+^Ca2+

B. Old Neuronal Cell:

H+
Ca2+

‘•A

A

Ca2+

a

Decreased SERCA Uptake and Compensation
■■■
Smooth Endoplasmic Reticulum
Ca2+
X SERCA
Ca2+ -(•)
>-►

PMCA
Ca2+

A

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

••
*•.

Mitochondria

rca2+ h+

Ca2+
H+

Na+

'A
Calcium Binding
Proteins
Ca2+^Ca2+ Ca2+^Ca2+
Ca2+^Ca2+

NT vesicle
release

®
®
®
® ®

m

26

Ca2+ H+ H+

rf

H+
Ca2+

Ca2+
H+
H+

H+

H+
H+
Ca2+

9.

CONCLUSIONS
It is important to keep in mind that observed alterations in the activities or

function of calcium regulatory systems may be an adaptive response to aging. It is
possible that the aging process induces subtle changes in the components responsible for
calcium regulation in adrenergic neurons, and this age-related effect may lead to
dysfunction of calcium homeostasis and dysregulation of NE release. However, it is also
possible that sustained changes in the regulation of [Ca2+]i may be one major cause of
neuronal degeneration and altered peripheral adrenergic nerve function with advancing
age. Despite our knowledge of the mechanisms involved in neuronal [Ca2+]i regulation,
elucidation of the importance and participation of each calcium buffering component is
still lacking, and additional studies are necessary to confirm their respective roles in
normal aging of central and peripheral nerves.
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1.

ABSTRACT
Adrenergic nerve smooth endoplasmic reticulum calcium buffering declines with

age. Calcium buffering capacity declines with age in sympathetic nerves of rat tail
artery. To test whether smooth endoplasmic reticulum (SER) calcium buffering declines
with age, effects of two SER calcium-ATPase inhibitors on norepinephrine release and
intracellular were determined. Thapsigargin or cyclopiazonic acid caused a significant
increase in stimulation-evoked norepinephrine release from 6 month tail arteries with
much less effect in 20 months. In isolated superior cervical ganglion cells, the rate of rise
of calcium with [K+]-depolarization increased only in young cells with either
cyclopiazonic acid or thapsigargin, with no effect in the old. In young cells,
cyclopiazonic acid significantly influenced time to peak, rate of decline, and time to basal
of [K+]-evoked [Ca2+]i-transients, but had no effect in old cells. Thapsigargin caused a
significant increase in rate of decline in young, but not old, cells. These differential
effects suggest an age-related decline in function of SER calcium buffering mechanisms
in the sympathetic nervous system causing older nerves to become more reliant on
mitochondria to buffer calcium.
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a2-adrenoceptors (Buchholz & Duckies, 1990; Buchholz, Tsai, Friedman & Duckies,
1992). Subsequent studies showed that in both the tail artery and isolated cells from the
superior cervical ganglion (SCG), inhibition of mitochondrial calcium uptake had a
greater impact in tissues from 20-month-old animals compared to those aged 6 months
(Buchholz, Tsai, Foucart & Duckies, 1996). These findings lead to the hypothesis that an
age-related decline in SER calcium handling mechanisms results in increased reliance on
mitochondrial calcium buffering and increased stimulation-evoked fractional
norepinephrine release.
To test this hypothesis, we used two structurally different SERCA inhibitors,
cyclopiazonic acid and thapsigargin, to interrupt normal sequestration of calcium by the
SER. If intracellular calcium homeostasis is less effective in older animals due to loss of
SER function, then we might expect blockade of these mechanisms to have little impact
on potassium ([K ])-evoked intracellular calcium concentration ([Ca ]i)-transients in
isolated SCG neurons from aged animals. In addition, we also measured stimulationevoked norepinephrine release from tail arteries in the present of cyclopiazonic acid and
thapsigargin. Using these SERCA inhibitors, we sought for evidence that a decline in
SER calcium buffering systems is implicated in the increased norepinephrine release with
advancing age in sympathetic nerves of the rat tail artery.
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3.

METHODS & MATERIALS

3.1

Experimental Animals
Male Fischer-344 (F-344) rats aged 6 and 20 months were obtained from the

NIH-NIA colony maintained by Harland Sprague-Dawley, Inc. (Indianapolis, IN). Rats
were anesthetized with CO2 and sacrificed by decapitation. Animals took food and water
ad libitum and were maintained on a 12 hr light/dark cycle under controlled temperature
(75 ± 2°F).

3.2

Measurement ofIntracellular Calcium
SCO cells were isolated by acute dissociation as previously described (Schofield,

1990). Briefly, whole ganglia were removed from the carotid artery bifurcation and
placed in cold Tyrode solution containing (in mM): NaCl, 150; KC1, 2; CaCb, 2; MgCb,
2; HEPES, 10; glucose, 10. Ganglia were minced, and the cells acutely dissociated in
Earle’s balanced salt solution to which were added trypsin (0.5 mg/mL), collagenase D (1
mg/mL), DNAse 1 type IV (0.1 mg/mL), 20 mM HEPES, 10 mM glucose, and 10 mM
NaHCCb. The pH was adjusted to 7.4 with NaOH. Ganglia were incubated in a shaking
water bath for 45 min at 34°C. The dissociated cells were resuspended in Hank’s
balanced salt solution to which were added 10% fetal calf serum and 5 mM HEPES with
final pH adjusted to 7.4. Cells were plated onto 22 mm cell-tak (3.5 pg/coverslip) coated
coverslips (2 ganglia/coverslip). Cells were allowed to plate down for 2 h at room
temperature.
Cells were loaded with fura-2 acetoxymethylester (fura-2 AM) (1 pM) for 20 min
at room temperature and then washed and left for 20 min to allow cell esterases to
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convert the dye to the free salt (Thayer, Sturek & Miller, 1988). Cover slips were
mounted in a chamber and rinsed in a buffer composed of (in mM) NaCl, 138; CaCh, 2;
MgCb, 1;KC1, 5; HEPES, 10; glucose, 10; pH adjusted to 7.4 with NaOH. The cell
chamber was attached to a Nikon inverted microscope interfaced with a Video-Probe
imaging system (ETM Systems, Irvine, CA). To change the solution in the chamber, a
volume five times larger than the chamber volume of 200 pL was rapidly injected. Thus
total volume exchange was achieved in less than 2 s. The fura-2 probe was illuminated
alternately at 340 and 380 nm, and emission fluorescence at 510 run was selected by a
barrier filter. Images were collected at a rate of 20 images/min. The ratio of 340/380 nm
fluorescence was converted to calcium concentration using the equation:
R-R min

fCa2+Ji = Kd~R

max-R Sf

Rmin and Rmax are determined using calcium standards at 0 pM calcium (Rmin) and 39 pM
calcium (Rma^). The constant Kd is the product of the dissociation constant of fura-2 (200
nM) and the ratio of the free and bound forms of the dye at 380 nm (Grynkiewicz, 1985).
Rate of rise and rate of decline to 90% recovery of [Ca2+]i were determined by linear fit
(mean r values of 0.989 and 0.979, respectively).
In experiments using cyclopiazonic acid, cells were initially depolarized for 30 s
with 68 mM [K+] followed by a 4-min equilibration period. The cells were then exposed
to 5 pM cyclopiazonic acid to block SER calcium uptake followed 3 min later by another
30 s depolarizaiton with 68 mM [K+]. In experiments using thapsigargin, cells were
depolarized for 50 s with 68 mM [K+] followed by a 5-min equilibration period. The
cells were then exposed for 10 min to 1 pM thapsigargin to block SER calcium uptake.

44

The drug was then washed out, followed by either a 5 min equilibration period or
addition of 100 pM dinitrophenol for 5 min. Finally, cells were depolarized again with
68 mM [K+] for 50 s.

3.3

Tail Artery Norepinephrine Release
Proximal segments of tail artery, 6 cm in length, were dissected and cannulated at

both ends with polyethylene tubing and placed into an in vitro low volume perfusion
system (Budai, Buchholz & Duckies, 1990). The entire assembly was kept at 37°C in a
circulating water bath. At the beginning of each experiment, tissues were perfused for 60
min with aerated (95% 02,5% CO2) Krebs’ solution containing 10"5 M cocaine, 10'5 M
deoxycorticosterone and 1 O’6 M idazoxan to inhibit neuronal uptake, extraneuronal
uptake and prejunctional ct2-adrenergic receptors, respectively. The composition of the
Krebs’ solution was (inmM): NaCl, 118; KC1, 4.8; CaCl2, 1.6; KH2PO4, 1.2; NaHC03,
25; MgS04, 1.2; ascorbic acid, 0.3; and glucose, 11.5.
Electrical field stimulation was delivered by a Grass S-48 stimulator through
platinum electrodes at either end of the tissue chamber. In experiments with
cyclopiazonic acid, parameters for excitation of perivascular nerves were 1.0 Hz, 60
volts, 1 ms duration, and 100 pulses. Tissues were stimulated (SI), then equilibrated in
Krebs’ with 5 pM cyclopiazonic acid for 30 min, and activated again, S2. In the
thapsigargin study, parameters for excitation of perivascular nerves were 60 volts, 1 ms
duration, and 100 pulses. Tissues were initally activated twice without thapsigargin at
0.25 Hz (SI) and 5.0 Hz (S2). Tissues were then equilibrated in Krebs’ with 5 pM
thapsigargin for 40 min and then washed for 30 min. Tissues were activated again, S3
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and S4, at 0.25 Hz and 5.0 Hz, respectively. A 20-min equilibration period was allowed
between S1/S2 and S3/S4.

3.4

Norepinephrine Quantitation
The perfusate was collected continuously starting at the beginning of each

stimulation period until 5 mL was collected. Basal norepinephrine release was monitored
by collection of 5 mL of perfusate between each treatment. Perfusates were extracted
and quantified with a dihydroxybenzylamine (DHBA) internal standard (300 pg)
following a previously described protocol (Budai et al, 1990). One third of the total
extracted sample of 300 pL (100 pL) was injected into an ESA coulochem 2 high
performance liquid chromatograph (ESA Inc., Bedford Mass, USA) using an ESA
reverse pahse C-18 column and 1 L of ESA MD-TM aqueous mobile phase containing, in
mM, Na2HP04, 75; sodium dodecyl sulfate, 0.5; EDTA, 0.025, 20% acetonitrile, and 5%
methanol. The amount of norepinephrine (NE) was calculated using the following
formula:
NE Peak Ht of Sample
Peak Ht DHBA standard
pg NE = Peak Ht NE standard 100 pg DHBA DHBA Peak Ht sample
Recovery varied from 80-90%.
Quantitation of total tissue norepinephrine content has been previously described
(Handa & Duckies, 1987). Briefly, arteries were taken at the end of the perfusion
experiment and homogenized in 3 mL of 0.1 N perchloric acid and centrifuged. Tissue
norepinephrine was then extracted similarly as the perfusate and used to calculate
fractional norepinephrine release:
pg NE release
Fractional NE release = (pg NE tissue content) (number of stimulation pulses)
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3.5

Statistical Analysis
Effects of cycopiazonic acid and thapsigargin on norepinephrine release and

calcium transients were analyzed by paired Student’s Mest. All data are presented as
mean ± SEM.

3.6

Materials & Solutions
DNAse-1 type IV, cyclopiazonic acid, thapsigargin, cocaine hydrochloride,

deoxycorticosterone, idazoxan, norepinephrine bitartrate, dihydroxybenzylamine, and
2,4-dinitrophenol were obtained from Sigma Chemical (St. Louis, MO, USA). Earle’s
and Hank’s balanced salt solutions were obtained from GIBCO (Grand Island, NY).
Collagenase D and trypsin were obtained from Boehringer-Mannheim (Indianapolis, IN).
Cell-Tak was obtained from Becton-Dickinson Labware (Bedford, MA). Fura-2 was
purchased from Molecular Probe Inc. (Eugene, OR).

4.

RESULTS
Stimulation-evoked norepinephrine release from the rat tail artery was measured

with neuronal and extraneuronal uptake blocked by 10'5 M cocaine and 10'5 M
deoxycorticosterone and oc2-adrenoceptors blocked by a maximal concentration of
idazoxan (10‘6 M; Buchholz et al., 1992). As in previous studies (Buchholz & Duckies,
1990; Tsai, Buchholz & Duckies, 1995), fractional norepinephrine release was
significantly higher in the 20-month-old tail arteries when compared to the 6-month-old
(132 ± 13, A = 9 compared to 98 ± 8,72 = 120 pg/pg content/pulse X 10"6; p < 0.05).
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When SER calcium uptake was blocked by 5 pM cyclopiazonic acid, fractional
norepinephrine release evoked by 1 Hz stimulation increased in 6-month-old rat tail
arteries, but cyclopiazonic acid had no significant effect in arteries from 20-month-old
rats (Fig. 1). A structurally different inhibitor of SER calcium uptake, thapsigargin, had a
similar differential effect on the two age groups. In the presence of 5 pM thapsigargin,
stimulation-evoked norepinephrine release significantly increased in arteries from both 6and 20-month old animals at frequencies of both 0.25 and 5 Hz. However, the effect of
thapsigargin on 6-month-old arteries was greater than on the 20-month-old arteries.
Basal norepinephrine release from 20-month-old arteries was significantly lower
than that of 6-month-old arteries in one set of experiments, but this was not noted in a
second experimental set (Table 1). Decreased basal release with age has been found in a
previous study (Tsai, Hewitt, Buchholz & Duckies, 1997). There were no differences in
the basal norepinephrine release after treatment with cyclopiazonic acid or thapsigargin.

EFFECT OF CYCLOPIAZONIC ACID OR THAPSIGARGIN ON BASAL NOREPINEPHRINE
RELEASE FROM THE TAIL ARTERY

Basal norepinephrine release (pg NE/pg content X 100)

Age

Control

Cyclopiazonic acid
(5 pM)

Control

Thapsigargin
(IpM)

6 Months

0.16 ± 0.03 (12)

0.13 ±0.02 (12)

0.15 ± 0.02 (16)

0.14 ± 0.01 (16)

20 Months

0.15 ± 0.03 (10)

0.17 ± 0.04 (10)

0.10 ± 0.01* (10)

0.11 ± 0.01* (10)

Table 1. Values represent the mean ± SEM with number of animals indicated in parentheses. All tissues
were treated with 10~5 M deoxycorticosterone, 10'5 M cocaine, and 10‘6 M idazoxan. * = significantly
different as compared to 6 months (unpaired Student’s f-test, p < 0.05).
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To extend our results, [Ca ]i was measured in acutely dissociated SCG cells
prepared from the same rats. Dissociated SCG neurons loaded with fura-2 showed a
stable basal calcium concentration that was not significantly different between cells from
6- and 20-month-old animals (58 ± \5, n = \ \ and 73 + 9 nM, n — 1, respectively;p =
0.50). When depolarized with 68 mM KC1, SCG neurons exhibited a rapid increase in
[Ca ]i that was reversed when the solution was returned to 5 mM KC1 (Fig. 2). The
mean amplitude of the calcium transient (peak calcium concentration minus resting
calcium concentration) due to 30 s depolarization was not significantly different between
the two age groups (Table 2).

EFFECT OF CYLOPIAZONIC ACID OR THAPSIGARGIN ON PEAK AMPLITUDE OF
[K+]-INDUCED CALCIUM TRANSIENTS IN SCG CELLS
Peak amplitude (nM)

Age

Control

Cyclopiazonic acid
(5 pM)

Control

Thapsigargin
(1 pM)

6 Months

155 + 13(11)

187+16(11)

585 ±81 (14)

683 ±85 (14)

20 Months

173 ±21 (7)

197 ± 32 (7)

659 ±61 (10)

644 ±78 (10)

Table 2. Values represent the mean ± SEM with number of animals indicated in parentheses.

Addition of 5 pM cyclopiazonic acid for 5 min resulted in a slight increase in
2_p .

[Ca ]i (Fig. 2), but there was no age-related difference in the calcium increase caused by
cyclopiazonic acid (26 ±l,n = \\ and 29 ±6, n = l nM for cells from 6- and 20-monthold rats, respectively). However, treatment with cyclopiazonic acid revealed clear
differences between nerve cells from 6- and 20-month-old rats when depolarizationinduced calcium transients were analyzed. With respect to the increasing calcium phase,
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rate of rise of [K ]-evoked [Ca ]-transients was not different among the age groups (Fig.
3 A). However, in the presence of cyclopiazonic acid, the rate of rise of [Ca2+]i in 6month-old cells was significantly increased, whereas cyclopiazonic acid did not change
rate of rise in 20-month-old cells. After exposure to cyclopiazonic acid, neurons from the
young SCG showed decreased time to peak, but there was no significant effect in the
aged tissues (Fig. 3B).
Analysis of the decreasing calcium phase also revealed clear and significant agerelated differences in the effect of cyclopiazonic acid on the process of re-establishment
of basal calcium following [K+]-depolarization. In the presence of cyclopiazonic acid,
the rate of decline of [Ca2+]i was significantly slowed in 6-month-old cells, but
cyclopiazonic acid had no significant effect on rate of decline in 20-month-old cells (Fig.
9+

3C). Time to reach basal [Ca ]i was significantly lengthened in 6-month-old cells by
cyclopiazonic acid treatment, but cyclopiazonic acid had no significant effect in cells
from 20-month-old animals (Fig. 3D).
In studies with 1 pM thapsigargin, time of exposure to 68 mM [K+] was increased
I

2+

from 30 to 50 s. This longer stimulation time produced a higher [K ]-evoked [Ca ]itransient (Fig. 4, Table 2). As in studies with cyclopiazonic acid, there were no agerelated differences found in the ability of thapsigargin to increase [Ca2+]i (110 ± 25, « =
11 and 108 ± 44, « = 6 nM for cells from 6- and 20-month old rats, respectively).
Blockade of SER calcium uptake with thapsigargin also had no effect on the amplitude of
[K+]-evoked [Ca2+]i-transients in 6- or 20-month-old neurons (Table 2).
As shown in Figure 5, when the rate of rise of the calcium transient was analyzed,
in 6-month-old cells the rate of rise was increased by thapsigargin, but the drug had no
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effect in 20-month-old cells (Fig. 5A). Thapsigargin had no significant effect on time to
peak in either young or old neurons (Fig. 5B). Interestingly, the rate of decline was
increased in the presence of thapsigargin, but only in 6-month-old cells (Fig. 5C).
Thapsigargin had no significant effect on time to basal calcium (Fig. 5D).
Finally, to evaluate residual calcium buffering capacity when both mitochondrial
and SER calcium uptake systems were blocked, cells were challenged with both 100 pM
dinitrophenol to block mitochondrial calcium reuptake and 1 pM thapsigargin to block
SER (Fig. 6). After treatment with both drugs, the peak amplitude of [K+]-evoked
[Ca ]i-transients was significantly increased in both young and old neurons (Fig. 7A).
Analysis of the increasing calcium phase showed that there was a significant increase in
the rate of rise in both age groups with dinitrophenol and thapsigargin treatment (Fig.
7B). The rate of decline, however, only increased in neurons from 20-month-old animals
(Fig. 1C).
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Figure 1. Effects of cyclopiazonic acid (5 juM, CPA) and thapsigargin (1 pM, TG) on
stimulation-evoked norepinephrine release in tail arteries from 6- and 20-month-old rats. Values
are presented as the ratio of S2 (in the presence of treatment) to SI (untreated). Nerves were
activated with electrical stimulation at the frequency indicated (60 volts, 1 ms duration). 10'5 M
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Figure 2. Effects of cyclopiazonic acid (5 pM) on [Ca2+]i in single freshly dissociated SCG cells
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5.

DISCUSSION
It has been suggested that neuronal calcium homeostasis declines with age, and

much attention has focused on the mitochondrial calcium buffering system (Gibson &
Peterson, 1987). Although extensive literature exists supporting the role of free radicals
in causing mitochondrial senescence in a variety of tissues, the degree of cellular
dysfunction due to mitochondrial damage or how much mitochondrial changes affect
organ function is still unclear (Hagen et al, 1997). Other mechanisms may mediate
aging in the nervous system. For instance, in hippocampal neurons, the increase in
calcium influx with age is mediated by increased expression of L-type calcium channels
(Campbell, Hao, Thibault, Blalock & handheld, 1996). In the sympathetic nervous
system, however, the mechanism for age-related changes in function is less clear. Here
we show evidence that decline in SER calcium buffering occurs while mitochondrial
calcium uptake is maintained in the peripheral sympathetic nervous system.
Previously, we have shown that when mitochondrial calcium buffering is blocked
with dinitrophenol, stimulation-evoked norepinephrine release increases in tail arteries
from 20-month-old animals whereas there is no change in 6-month-old arteries (Tsai et
al., 1995). This is also true in acutely dissociated SCG neurons in which addition of a
mitochondrial inhibitor increases peak calcium and rate of rise of [K ]-evoked [Ca ]itransients only in cells from 20-month-old animals (Buchholz et al, 1996). Thus, it is of
significance that, in the present study, the SERCA inhibitors, cyclopiazonic acid and
thapsigargin, had a greater effect in increasing norepinephrine release from young tail
arteries compared to old (Fig. 1). Likewise, in acutely dissociated SCG neurons prepared
concurrently, cyclopiazonic acid and thapsigargin only had effects in cells from young

59

animals (Figs. 3 & 5). Together, these results clearly demonstrate age-related differences
in calcium homeostatic mechanisms when tissues from 6- and 20-month-old animals are
compared.
One interpretation of the results of the present study is that SER is the
predominant buffer in the young tissues, while 20-month-old tissues rely more heavily on
mitochondrial calcium buffering. In support of this interpretation, neither cyclopiazonic
acid (Fig. 3) nor thapsigargin (Fig. 5) had any effect on calcium transients in SCG cells
from 20-month-old animals, but the cells did have changes in peak amplitude, rate of rise,
and rate of decline when a mitochondrial inhibitor, dinitrophenol, was added after
thapsigargin treatment (Fig. 7). Interestingly, rate of decline in the 20-month-old SCG
neurons increased in the presence of both dinitrophenol and thapsigargin, whereas there
was no change in the young (Fig. 7C). Thus, it seems that all the calcium buffering
systems, except for SER, are more activated in the aged neurons. This supports the
hypothesis that decline in the SER calcium buffering system forces other calcium
buffering systems such as the mitochondria to compensate.
Effects of cyclopiazonic acid and thapsigargin on young cells were not identical.
This may be due to a longer [K+]-depolarization time of 50 s for studies with thapsigargin
compared to 30 s in experiments with cyclopiazonic acid. Indeed, as shown in Table 2,
control peak calcium transients were higher with 50 s exposures to high [K+] compared
to 30 s exposure. Interestingly, with stimulation for 50 s the rate of decline was increased
in the presence of thapsigargin (Fig. 5C), in striking contrast to the decreased rate of
decline caused by cyclopiazonic acid after 30 s depolarization (Fig. 3C). One
explanation is that, due to the kinetics of mitochondrial calcium uptake, at the higher
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calcium concentrations seen with prolonged stimulation mitochondrial calcium uptake
may be greater, especially when SER calcium buffering systems are blocked. To
demonstrate that this increased rate of decline seen with thapsigargin in young cells could
be due to mitochondrial activation, we added the mitochondrial inhibitor, dinitrophenol,
together with thapsigargin, and in this case there was no change in the rate of decline in
6-month-old cells (Fig. 1C). Thus these results suggest that in cells from young SCG
both the SER and mitochondrial calcium buffering systems are functional, and that the
mitochondrial calcium buffer system is activated with longer [K+]-depolarization and in
the presence of thapsigargin.
It is unlikely that the differential effects seen with cyclopiazonic acid and
thapsigargin on old versus young tissues were due to an age-related decrease in
sensitivity to the drugs, because there were no age-related differences in the ability of
cyclopiazonic acid or thapsigargin to release calcium from intracellular stores under basal
conditions. Therefore, it seems that SERCA’s buffer calcium in the 20-month-old
neurons under basal conditions, but do not function as well during [K+]-induced
depolarization. This may be due to changes with age in spatial relationships between
intracellular organelles revealing that calcium signaling and buffering are highly
compartmentalized (Golovina & Blausein, 1997; Thomas, Bird, Hajnoczky, RobbGaspers & Putney, 1996).
Another important issue that must be addressed concerns the possibility that there
is an age-related difference in the amount of fura-2 taken up by the superior cervical
ganglion cells or a difference in the activity of non-specific esterases that convert fura2/AM to the free salt. Any age-related change in these parameters could result in
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erroneous estimations of the [Ca ]i. One way to assess this is to examine the maximum
intensity of the fluorescence signal at 510 nm when the dye is activated at 380 nm with
zero Ca2+ (Negulescu & Machen, 1990). The intensity of the signal is then proportional
to the amount of dye loaded into each individual cell. We have not found any age-related
change in the fluorescence signal at 510 nm when fura-2 is activated at 380 nm,
suggesting that dye loading is equivalent in young and old cells. Thus, age-related
differences in dye loading do not seem to be an issue in our study.
The most significant finding in this study is that there is no effect in tissues from
20-month-old animals when SER calcium uptake mechanism is blocked, suggesting a
decline with age in the function of SER. What are the mechanisms that underlie this agerelated decline in SER? One possibility is that expression of SERCAs may be decreased
with age. Sarcoplasmic reticulum buffering with age has been shown to decrease in
cardiac myocytes (Hano et al, 1995), and this has been attributed to a reduction in
expression of the gene coding for one SERCA subtype (Lompre, Lambert, Lakatta &
Schwartz, 1991; Maciel, Poliker, Rohrer, Popovich & Dillmann, 1990). We are currently
determining the subtypes and comparing the expression of SERCAs in the SCG with age
to test this hypothesis.

In conclusion, we have clearly shown a significant age-related change in
intracellular calcium buffering in adrenergic nerves. Loss of neuronal calcium
homeostasis has been suggested to be the key final pathway in age-related decline in
brain function (Landfield, 1992). Thus, our findings in adrenergic nerves innervating the
rat tail artery and SCG neurons start to define an important aspect of cellular function that
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is impacted by advancing age. Further studies would be needed to explore the possibility
that this functional change defined in nerves of the autonomic nervous system may have
more widespread applicability to age-related changes in other parts of the nervous
system.
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1.

ABSTRACT
Adrenergic nerves compensate for a decline in calcium buffering during aging.

We explored the impact of age on the function of Ca -ATPase systems of the plasma
membrane and endoplasmic reticulum. We used the selective ranges of vanadate to block
the effects of PMC As (0.05 - 0.25 pM) over SERCAs (0.5 - 100 pM) and observed a
biphasic effect on rate of recovery of [Ca2“b ]i in young (6 month) SCO cells compared to
only a single phase response on old (20 month) animals. These data suggests that
PMCAs are functioning in both young and old SCG cells; however, the function of
SERCAs declines in old SCG cells. We studied the contribution of mitochondrial
o I

calcium uptake with age by removing the contribution of Ca -ATPase systems (PMCAs
and SERCAs) with vanadate (100 pM) and Na /Ca -exchangers with replacement of
[Na+]e with tetraethylammonium. In the presence of these blockers young and old SCG
cells showed no change in recovery of [K+]-evoked [Ca2+]i-transients, suggesting that the
capacity of mitochondrial calcium uptake does not change with age. These data together
suggest that despite an age-related decline in SERCA function, PMCA and mitochondrial
function appear to be maintained with age and provide compensation in calcium
buffering capacity in neurons.
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2.

INTRODUCTION
2_j_

Intracellular calcium ([Ca ]i) is an ubiquitous second messenger that integrates
multiple and diverse neuronal pathways including development and maturation, gene
expression, cell death, synaptic plasticity, transmitter release, and excitability (Malenka et
al, 1989; Choi, 1992; Clapham, 1995; Ginty, 1997; Spitzer & Ribera, 1998). Calcium
homeostasis involves the cooperation of several calcium buffering components that work
in concert to restore stimulation-evoked calcium signals to basal levels (Kostyuk &
Verkhratsky, 1994). Mechanisms of calcium buffering include: calcium sequestration
into endoplasmic reticulum (ER) by sarco/endoplasmic reticulum Ca -ATPase (SERCA)
pumps (Wuytack et al, 1992; Wuytack et al, 1995); mitochondrial calcium uptake via an
electrophoretic Ca2+/H+-uniporter (Werth & Thayer, 1994; David et al, 1998; Pinton et
al, 1998); cytosolic calcium binding proteins (Miller, 1995); plasmalemmal calcium
extrusion via plasma membrane Ca2+-ATPase (PMCA) pumps (Carafoli, 1997) and
plasma membrane Na /Ca -exchange (Blaustein & Lederer, 1999).
Two families of P-type Ca2+-ATPase pumps are vital for the regulation of [Ca2+]i
transients: PMC As that extrude calcium to the extracellular space (Werth et al, 1996;
Carafoli, 1997) and SERCAs that sequester calcium into the ER (Inesi & Kirtley, 1992;
Tsai et al, 1998). Functional characterization of SERCAs has been studied with several
selective blockers, the most well known being thapsigargin, cyclopiazonic acid, and 2,5di(terr-butyl)-l,4-benzohydroquinone (Seidler et al, 1989; Lytton et al, 1991; Khan et
al, 1995).
To block the contribution of PMC As has been more difficult. No rigidly
selective, easily administered blockers can inhibit the activity of PMC As alone.
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However, a useful pharmacological tool for studying the function of Ca2+-ATPase
systems is the phosphate analog sodium orthovanadate (NasVC^) (Simons, 1979; Bond &
Hudgins, 1980; Caroni & Carafoli, 1981). The two Ca2+-ATPase activities have been
distinguished using vanadate in rat and pig purified brain synaptosomes (enriched
PMC As) and microsomes (enriched SERCAs) (Michaelis et al., 1987; Salvador & Mata,
1998). Salvador and Mata showed that PMC As exhibit a greater sensitivity to vanadate
(K1/2 = 0.1 pM) over SERCAs (Ki/2= 0.4 pM), and that this agent can be used to
•
characterize
the two Ca2“b -ATPase systems.

In recent years our understanding of mitochondria as another major component of
the calcium buffering system has undergone substantial revision. Early studies suggested
that mitochondria only buffer calcium under non-physiological conditions when [Ca2+]i
exceeds 2 pM (Nicholls, 1985) or in pathological states (Wilson et al., 1984; Khandoudi
et al., 1989). Recent studies have shown that mitochondria buffer [Ca2+]i loads within
normal physiological ranges and in the absence of pathology (Werth et al., 1994;
Buchholz et a/., 1996; David et al, 1998; Rizzuto et al., 1998).
The pervasive involvement of calcium in multiple neuronal pathways has led
94-

•

•

investigators to suggest that dysfunction of [Ca ]i homeostasis may be a primary
mediator of age-related neuronal degeneration (Gibson & Peterson, 1987; Khachaturian,
1994; Landfield, 1996). While this is a generally accepted hypothesis, there is little
information on age-related changes in specific calcium regulatory systems. Furthermore,
as discussed above, multiple mechanisms can potentially compensate for an age-related
decline in function of one or more components of the calcium buffering system. For
example, our studies in superior cervical ganglion (SCG) cells have shown that there is
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an age-related decline in SERCA function (Tsai et al, 1997; Tsai et al, 1998). In
support, SERCA expression in cardiac tissue and pancreatic p-cells has also been shown
to decline with age (Maciel et al., 1990; Varadi et al., 1996). However, despite the agerelated decline in SERCA buffering, it has been suggested that mitochondria and
plasmalemma calcium extrusion can compensate for either a decline in SERCA buffering
capacity or an age-related increase in neuronal calcium influx (Buchholz et al, 1996;
Tsai et al., 1998; Murchison & Griffith, 1998).
94-

To explore the impact of age on the function of Ca -ATPase in plasma
membranes and ER, our first study investigated the contributions of PMC As and
SERCAs to control [K+]-evoked [Ca2+]i-transients in SCG cells. Changes in [Ca2+]i were
measured by fura-2 microfluorometry. The governing hypothesis is that an age-related
decline in SERCA function is partially compensated for by an increase in PMCA
function. To test the function of Ca2+-ATPases to control [Ca2+]i transients in
sympathetic neurons, we utilized the differential sensitivity of PMC As and SERCAs to
vanadate. We anticipated that in young SCG cells the concentration vs. blockade of
Ca2+-ATPases would reveal a biphasic response over the concentration range used (0.01
100 pM). Furthermore, we expected that in aged SCG cells vanadate at high
concentrations (> 0.25 pM) would have no further blocking effect after inhibition of
PMCAs, supporting a decline in SERCA function.
The second study examined the impact of age on the ability of mitochondrial
9-1-

calcium buffering to regulate [Ca ]i in the same young and old SCG cell model. To
force the SCG to rely on mitochondrial calcium buffering, the contribution of PMCAs
and SERCAs was blocked with a high vanadate concentration (100 pM), and
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extracellular sodium ([Na+]e) was replaced with tetraethylammonium (TEA) to block
Na+/Ca2+-exchangers. Changes in [Ca2+]i were measured by fura-2 microfluorometry.
This protocol allows for the investigation of the relative contribution and capacity of
mitochondria to buffer Ca -transients in SCG cells. Our previous studies have
demonstrated that there is a greater reliance on mitochondria to buffer Ca -transients
with age. Therefore, our hypothesis in this study is that mitochondrial calcium uptake is
maintained with age despite a decline in SERCA function.

3.

MATERIALS & METHODS

3.1

Experimental Animals
Male Fischer-344 (F-344) rats aged 6- and 20-months were obtained from NIH-

NIA breeding colony (Harlan Sprague-Dawley, Inc., Indianapolis, IN). Animals took
food and water ad libitum and were maintained on a 12 hr light/dark cycle under
controlled temperature (75 ± 2°F).

3.2

Superior Cervical Ganglion Preparation
SCG cells were isolated by acute dissociation as previously described (Tsai et al.,

1998). Briefly, rats were anesthetized with CO2 followed by decapitation. SCG were
dissected from the carotid artery bifurcation and placed in cold Tyrode’s solution
containing (in mM): NaCl, 150; KC1, 4; CaCb, 2; MgCb, 2; N-(2-hydroxyethyl)
piperazine-N'-2-ethanesulfonic acid (HEPES), 10; and glucose 10. The ganglia were then
acutely dissociated in 5 mL of Earle’s balanced salt solution (BBSS) containing: trypsin
(0.5 mg/mL; -6000 units/mL), collagenase D (1 mg/mL), DNAse-1 type IV (0.1
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mg/mL), HEPES (20 mM), glucose (10 mM), and NaHCOs (10 mM), pH adjusted to 7.4
with NaOH. After incubation in a shaking water bath for 45 min at 34°C, the digestion
reaction was terminated by the addition of 5 mL of modified Hank’s balanced salt
solution (HESS) with 10% fetal calf serum, CaCb (1.3 mM), and HEPES (5 mM), pH
adjusted to 7.4 with NaOH. The dissociated cells were then lightly pelleted at 600 rpm
(60 x g) for 5 min, the supernatant removed, gently re-suspended in 5 mL of fresh HESS,
and pelleted again at 600 rpm (60 x g) for 5 min. Cells were dispersed in 0.5 mL of
HESS onto Cell-Tak protein coated glass coverslips modified by attaching a 2 cm Teflon
ring to the surface with Sylgard. Coverslips were incubated for 2 hr at room temperature
to allow cell attachment to the Cell-Tak protein coat before further treatment.

3.3

Measurement ofIntracellular Calcium
A dual wavelength ratiometric fura-2 microfluorimetry system was used to

measure [Ca2+]i in SCG cells. SCO cells were loaded with 10 pM fura-2
acetoxymethylester (fura-2/AM) for 20 min at room temperature, then washed with 5 mL
of low [K+] (5 mM) buffer composed of (in mM): NaCl, 138; CaCh, 2; MgCh, 1; KC1,
5; HEPES, 10; glucose, 10; pH adjusted to 7.4 with NaOH. Incubation was continued for
an additional 20 min to allow intracellular esterases to convert the fura-2/AM dye into the
free acid form (Thayer et al., 1988). Coverslips were mounted into a superfusion
chamber, which was attached to the stage of a Nikon inverted microscope (Nikon Instr.,
Tokyo, Japan). The microscope was attached to a Universal Imaging System running
MetaFluor version 3.0 (Universal Imaging Corp., West Chester, PA). The perfusion
system allowed the chamber volume (-250 pL) to be exchanged at the rate of 500 pL/sec
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(i.e. 2 times/sec). A suitable cell was distinguished as a rounded cell body isolated from
other cells and has localized phase-contrast illumination of the fura-2 probe. A mercury
vapor lamp illuminated the fura-2 probe, and fluorescence was excited alternately at
wavelengths 340 and 380 nm by a Sutter-II rotating filter wheel. The fura-2 emission
fluorescence at 510 nm was selected by a barrier filter and recorded by a CCD
Hamamatsu imaging camera. Adjusting the microscope stage to a point with no cells in
the field of view and capturing a background image before the start of the experiment
corrected for background light levels. Prior to fura-2/AM loading, cellular
autofluorescence was examined in SCO cells. Autofluorescence was found to be
2+ .

undetectable by our imaging system and did not significantly alter our [Ca ]i
measurements. During the experiment, 340 and 380 images were collected at a rate of 4
boxcar-averaged images/sec, corrected for background fluorescence, calcium
concentration calculated, and the data logged to a text file. During dye loading and data
collection, ambient light levels were minimized and neurons were only illuminated
during data acquisition to minimize bleaching and potential photo damage of the dye.
Intracellular calcium was estimated by both in vitro and in vivo calibration
methods. The in vitro method was performed using a calcium calibration kit (Molecular
Probes, Eugene, OR) with known [Ca2+] ranging from 0-40 pM. Each prepared
calcium solution was loaded with 4 pM fura-2 pentapotassium salt. A droplet of each
[Ca2+] was placed onto a glass slide and the fluorescent intensities from 340 and 380
excitation were measured and a curve of 340/380 ratio (R) vs. [Ca ] was plotted. The in
vivo method was performed on SCG cells by decreasing extracellular calcium
concentration to 0 mM, and fluorescence from 380 (Fmjn) and 340/380 ratio (Rmin) was
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recorded for 1 min. The extracellular medium was then replaced with 10 mM [Ca ] with
ionomycin (1 pM) and depolarized with high potassium (68 mM). Values were then
recorded for 1 min to obtain Fmax and Rmax- The values for Fmin, Rmin, Fmax, and Rmax were
remarkably similar between the in vitro and in vivo method. Our in vitro calibration for
Kd is comparable to in vivo values in neuronal cells (Neher, 1995; Murchison et al.,
1998). Furthermore, we applied the same Kd for both young and old SCO neurons, since
previous reports have shown no significant change in fura-2 Kd values for young and old
neurons (Murchison et al, 1998). Since our in vitro method correlated well with in vivo
measurements, the values obtained from the in vitro calibration were used to convert the
experimental fluorescent intensity ratios (R) to [Ca ] over the physiological range of
[Ca ]i by iterative fit to the equation:
R-R min

[Ca2+]i = Kd J

max-R Sf

Rmin is the 340/380 ratio at zero [Ca2+] and Rmax is the 340/380 ratio at 40 pM [Ca2+].
The value of Kd is the dissociation constant of fura-2, while Sf is a correction factor
relating the ratio Fmin/Fmax, which is the emission intensity at 380 nm when fura-2 is in
the free (Fmin; 0 pM [Ca2+]) or bound (Fmax; 40 pM [Ca2+]) form (Grynkiewicz et al,
1985). For this report, the [Ca2+]i was estimated using averaged in vitro values for Sf
(7.6), Rmin (0.33), Rmax (2.75), and Kd (251 nM).

3.4

Experimental Protocols
To characterize the effects of vanadate on PMCAs and SERCAs, SCG cells were

first depolarized (SI, control) for 15 sec by superfusion with Tyrodes buffer containing
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68 mM KC1 followed by a wash out with low [K+] (5 mM) buffer and a 2 min
equilibration period. Cells were then exposed to a selected vanadate concentration
ranging from 0.01 to 100 pM and allowed to equilibrate for 2 min. Again cells were
depolarized for 15 sec with Tyrodes buffer containing 68 mM [K+] and vanadate (S2).
Exposure to increasing concentrations of vanadate (0.01 - 100 pM) was repeated for S3
and S4. The SCG cells were divided into three groups for each age (6- and 20-month)
and exposed to the following vanadate concentrations (in pM): Group A: 0.01, 0.05, 0.1;
Group B: 0.25, 0.5, 1.0; and Group C: 1.0, 2.0, 100.
For studies using vanadate and TEA to study mitochondrial calcium uptake
function, SCG cells were initially depolarized (SI, control) for 15 sec by superfusion
with Tyrodes buffer containing 68 mM KC1 followed by a wash out with low [K+] (5
mM) and a 2 min equilibration period. SCG cells were then exposed to 100 pM vanadate
for 4 min to block the Ca2+-ATPase systems of PMCAs and SERCAs. Finally, zero
sodium (Na+ replaced with TEA) was added to block the Na+/Ca2+-exchanger, and SCG
cells depolarized (S2) for 15 sec in the presence of 68 mM KC1, 100 pM vanadate, and
zero sodium.

3.5

Data Analysis
The resting [Ca2+]i for SCG cells was recorded as a long segment (50-60 sec) of

fluorescence ratio signal before initial depolarization of the cell. The peak change in
[Ca2+]i was measured by subtracting the baseline [Ca2+]i from the observed peak [Ca2+]i.
The baseline [Ca2+]i was measured as the mean [Ca2+]i 1-2 sec immediately before each
[Ca2+]i transient. The rate of recovery of [Ca2+]i (nM/s) was measured from the peak
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change in [Ca2+]i to within 90% recovery to baseline. Rate of rise of [Ca2+]i (nM/s) was
9+ •

9-4-

determined by measuring from baseline [Ca ]i to peak [Ca ]i. The rate of decline and
rate of rise of [Ca ]i were determined by linear fit regression (mean r values of 0.975
and 0.970, respectively).

3.6

Statistical Analysis
The effect of age on the response of calcium transients to treatment with vanadate

and vanadate/TEA was analyzed by Student’s paired Mest and two-way ANOVA with
Fischer-PLSD test. Data are presented as mean or mean % of control ± SEM.

3.7

Materials & Solutions
DNAse-1 type IV, trypsin, fetal calf serum, and vanadate were obtained from

Sigma Chemical (St. Louis, MO). Fura-2/AM from Molecular Probes (Eugene, OR).
Earle’s and Hank’s balanced salt solution from GIBCO (Grand Island, NY). Collagenase
D from Boehringer-Mannheim (Indianapolis, IN). Cel-Tak from Collaborative
Biomedical Products (Bedford, MA). Sylgard from Dow Coming Corp. (Midland, MI).

4.

RESULTS

4.1

Resting [Ca ]i Measurements

2 A-

Acutely dissociated SCG cells prepared from 6- and 20-month-old rats were
loaded with fura-2 and showed a stable basal [Ca2+]i that was indistinguishable between
the two age groups (6 month: 91 ± 6 nM, V= 35 and 20 month: 98 ± 12 nM, V= 24).
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4.2

Effect of Ca2+-ATPase Blockade
When SCG cells were depolarized for 15 sec by superfusion with 68 mM KC1,

[Ca ]i increased rapidly, then was restored to basal levels when the solution was
replaced with 5 mM KC1 (Fig. 1). Exposure of SCG cells to low concentrations of
vanadate (0.25 pM) to block the PMCA contribution resulted in a decline in rate of
recovery of [Ca ]i in 6-month-old, with a greater effect in 20-month-old cells (Fig. 1 A,
inset i; Fig. 1C, inset ii). However, when the vanadate concentration was increased (1.0
pM), to block both PMCAs and SERCAs, an additional decline in rate of recovery of
[Ca2+]i occurred in 6-month, but no significant further effect was observed in 20-monthold cells (Fig. IB, inset i; Fig. ID, inset ii). Comparison of control values of time to
recovery and rate of recovery for [K+]-evoked [Ca2+]i-transients showed no significant
difference between the two age groups, however, 20-month SCG cells showed a
significant increase in peak height (Table 1). Exposure to high vanadate (100 pM) did
not significantly alter peak height, time to peak, or rate of rise of [Ca2+]i when compared
to control values in either age group (Table 2).
CONTROL VALUES FOR [K+]-EVOKED [Ca2+]i-TRANSIENTS FROM SCG CELLS

Young
(6-month)

Old
(20-month)

Time to Recovery (sec)

10.4 ± 0.7

10.9 ± 1.0

Rate of Recovery (nM/sec)

44.6 ± 4.0

45.3 ± 4.3

436.5 ± 25.1

530.3 ± 34.5 *

Peak Height (nM)

Table 1. Values represent mean ± SEM. Values were compared by unpaired T-test. * = significantly
different from 6 month control (p < 0.05). N = 55 cells from 24, 6-month-old animals and 47 cells from
24, 20-month-old animals.
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EFFECT OF HIGH VANADATE (100 fiM) ON [K+]-EVOKED [Ca2+]i-TRANSIENTS
IN SCG CELLS
(PERCENT OF CONTROL)

Young
(6-month)

Old
(20-month)

Peak Height (nM)

96.1 ± 3.1

96.8 ± 15.6

Time to Peak (sec)

104 ± 9.6

106 ± 6.6

Rate of Rise (nM/sec)

100 ± 7.9

105 ± 12.4

Table 2. Values represent mean % of control ± SEM. Effects of treatments were determined by two-way
ANOVA with repeat measures and Fisher-PLSD-test, or paired Student’s Mest. N = 31 cells from 8, 6month-old animals and 24 cells from 8, 20-month-old animals.

Exposure of SCG cells to the Ca2+-ATPase blocker vanadate at high
concentrations (> 0.5 pM) that block both PMCAs and SERCAs consistently induced a
cytosolic calcium spike in 14 of 18 SCG cells from 6-month-old compared to only 2 of
17 cells from 20-month-old animals (Fig. 1B,D). Low vanadate concentrations ( < 0.5
pM), which selectively block PMCAs, did not induce cytosolic calcium spikes in either 6
or 20-month-old SCG cells (Fig. 1 A,C).
In the presence of vanadate at low or high concentrations, the rate of recovery of
[Ca2+]i was significantly reduced, and time to recovery of [Ca2+]i was significantly
increased in both 6- and 20-month SCG cells (Fig. 2A,B). Analysis of rate of recovery
and time to recovery of [Ca2+]i elucidated a number of points of interest. First, vanadate
produced a biphasic response in SCG cells from 6-month-old animals, which contrasted
to a single-phase response in 20-month-old (Fig. 2A,B). Secondly, the low vanadate
range (0.01 - 0.25 pM), which is thought to selectively block PMCAs and not
significantly affect SERCAs, produced a change in these parameters in both 6- and 20-
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month-old SCG cells, with a greater effect in 20-month (Fig. 2A,B). Thirdly, the high
vanadate range (0.5 - 100 |aM), which is thought to block both PMC As and SERCAs,
produced an additional change in these parameters only in 6-month SCG cells, with no
further significant change in 20-months (Fig. 2A,B).

4.3

Vanadate Selectivity for PMCAs
To confirm the effects of low vanadate concentrations on PMCAs we first

blocked SERCAs with the selective SERCA blocker thapsigargin. Vanadate (0.1 pM)
was then applied to observe if this concentration of vanadate had any additional affect on
rate of recovery of high [K+]-evoked [Ca2+]i-transients. Young SCG cells exposed to
thapsigargin (0.5 pM) showed a significant decline in rate of recovery of [Ca ]i
compared to control. Addition of a low vanadate concentration (0.1 pM), which is
thought to primarily block PMCAs, showed a significant and further decline in rate of
recovery of [Ca2+]i compared to treatment with thapsigargin alone. Subsequent exposure
of thapsigargin treated cells to a high concentration of vanadate (1.0 pM) showed no
2+

significant further change in rate of recovery of [Ca ]i (Table 3).
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SELECTIVE EFFECTS OF VANADATE ON PMCA IN THE PRESENCE OF THAPSIGARGIN IN
6-MONTH-OLD SCG CELLS

Treatment

Rate of Recovery
(nM/sec)

Control

Thapsigargin
(0.5 pM)

Low Vanadate
(0.1 pM)

High Vanadate
(1.0 faM)

52.01 ± 9.9

33.28 ± 4.2 *

19.27 ± 2.9 +

18.13 ± 3.3

Table 3. Values represent mean ± SEM. SCG cells were exposed to 68 mM KC1 for 15 sec to evoke
[Ca2+]i-transients and then washed with 5 mM KC1 to allow calcium buffering systems to restore [Ca2+]i.
Values were compared by paired Student’s t-test. * = significantly different from SI control (p < 0.05).
+ = significantly different from S2 treatment with thapsigargin (0.5 pM) (p < 0.05). N = 6 cells from 4,
6-month-old animals.

4.4

Role ofMitochondria
In addition to studying the contributions of Ca2+-ATPase systems to control [K+]-

evoked [Ca2+]i-transients, we investigated the role of mitochondrial calcium uptake in
SCG cells. Therefore, we blocked PMC As and SERCAs with 100 pM vanadate and the
Na+/Ca2+ exchanger by replacing [Na+]e with TEA. Under these conditions SCG cells
will rely on mitochondria to control [K+]-evoked [Ca2+]i-transients. As shown in figure
3, following the initial high [K+]-evoked [Ca2+]i-transients (SI), cells were exposed to
100 pM vanadate. This induced a calcium spike in 20 of 28, 6-month-old cells, while
only 5 of 23, 20-month cells responded in this way to the addition of vanadate. When
[Na+]e was replaced with TEA and 100 pM vanadate was present, there was a decline in
rate of recovery of [K+]-evoked [Ca2+]i-transients (S2) in both 6- and 20-month cells
(Fig. 3, inset i,ii). In the presence of 100 pM vanadate and TEA, the rate of recovery
and time to recovery of [K+]-evoked [Ca2+]i-transients were both significantly altered
with no significant differences in age (Fig. 4).
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Figure 1. Representative tracings of the effects of vanadate on [K+]-evoked [Ca2+]i-transients in
single, freshly dissociated SCG cells from 6-month (A,B) and 20-month-old (C,D) rats. Effects
of low vanadate concentration (0.25 pM) are shown in A and C, and effects of high vanadate
concentration (1.0 pM) are shown in B and D. Figure insets (i-iv) illustrate rate of recovery of
[Ca2+]i after [K+]-evoked depolarization of control (SI) and treated (S2) cells with an expanded
time scale to resolve changes in recovery. Rate of recovery was analyzed by best fit linear
regression with an average R2 of 0.982 for control and 0.972 for treated [Ca2+]i-transients. Fura-2
loaded cells were depolarized (SI, Control) for 15 sec with Tyrodes buffer containing 68 mM
[K+], followed by a 2 min equilibration in normal 5 mM [K+] Tyrodes. Cells were then exposed
to Tyrodes with vanadate (0.25 or 1 pM) for 2 min and then depolarized for 15 sec with Tyrodes
containing 68 mM [K+] and vanadate (S2) followed by a 2 min equilibration.
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Figure 2. (A) Effects of the Ca2+-ATPase inhibitor, vanadate (0.01 - 100 pM), on rate of
recovery of [Ca2+]i in SCG cells from 6- and 20-month-old animals. (B) Effects of vanadate
(0.01 - 100 pM), on time to recovery of [Ca2+]i in SCG cells from the same age groups. The light
gray area represents the low range of vanadate concentration, while the dark gray area represents
the high range of vanadate concentration. Rate of recovery of [Ca2+]i was determined by linear
regression analysis from peak [Ca2+]i levels to 90% of recovery to basal [Ca2+]i, then adjusted to
% of control. Time to recovery of [Ca2+]i was determined by the difference in time from peak
[Ca2+]i levels to 90% of recovery to basal [Ca2+]i, then adjusted to % of control. Values are
expressed as % of control. Effects of treatments were determined by two-way ANOVA with
repeat measures and Fisher-PLSD test, or paired Student’s /-test. * = Significantly different from
control,/? < 0.05. + = Significantly different from 0.25 pM (-6.6 on x-asis) vanadate,/? < 0.05. N
= 35 cells from 8, 6-month-old animals and 24 cells from 8, 20-month-old animals.
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Figure 3. Representative tracings of the effects of vanadate and zero Na+ on [K+]-evoked [Ca2+]itransients in SCG cells from (A) 6-month-old and (B) 20-month-old rats. Effects of addition of
vanadate (100 jiM Va) and zero Na+ (replacement of Na+ with TEA) are shown. Figure insets (i,
ii) illustrate rate of recovery of [Ca2+]i after [K+]-evoked depolarization of control (SI) and
treated (S2) cells with an expanded time scale to resolve changes in recovery. Rate of recovery
was analyzed by best fit linear regression with an average R2 of 0.98 for control and 0.96 for
treated Ca2+-transients. Fura-2 loaded cells were depolarized (Control, SI) for 15 sec with
Tyrodes buffer containing 68 mM [K+], followed by a 2 min equilibration. Cells were then
exposed to 100 p.M vanadate for 4 min. Again cells were depolarized (Va + TEA, S2) for 15 sec
with Tyrodes buffer containing 68 mM [K+], vanadate, and zero Na+ (143 mM TEA) followed by
a 2 min equilibration.
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DISCUSSION

5.1

Technical Considerations
The use of fluorescent calcium sensitive probes can introduce potential sources of

error, which merit discussion (Moore et al., 1990; Kao, 1994; Neher, 1998). The [Ca2+]i
values we report are estimates and not absolute values. Therefore, the comparison of
•

•

94. ,

age-related changes in calcium buffering is the relative difference in [Ca ]i observed
between the two age groups. For age comparisons, we pair depolarizations under treated
9-4-

9-1-

conditions with control stimulations for each cell. Resting [Ca ]i, peak [Ca ]i, and the
rates of rise and recovery (nM/sec) reported are well within the accepted physiological
ranges reported in neurons and other cells (Neher, 1995; Murchison et al, 1998). In
9 I

9_|_

these experiments peak [Ca ]i transients are typically below 1.0 pM [Ca ]i. Therefore,
peak [Ca ]i transients fall within the linear range (0.02 - 2.0 pM [Ca ]) of the in vitro
calibration curve for fura-2. Additionally, there appeared to be little evidence of
incomplete hydrolysis or compartmentalization of the fura-2/AM dye (Zhou & Neher,
1993). The short loading time and low concentration of fura-2/AM combined with low
temperature and long de-esterification time minimizes these possible sources of error.
It has been suggested that the digestion process may differentially affect fura-2
loading for young and aged SCG cells and may be responsible for our observed agerelated effect. When cells are at rest, the 380 nm signal is a comparative indicator of
fura-2 loading (Negulescu & Machen, 1990). The 380 nm signals are remarkably similar
between young and old SCG cells (6 month: 89.27 ± 2.57; 20 month: 90.72 ± 3.53 Fsso,
emission intensity of fura-2 excited at 380 nm). This strongly suggests that the acute
dissociation process does not introduce a sampling artifact, compromise data, or alter
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fura-2 loading in SCG cells. Our basal [Ca ]i levels are comparable with values
reported in central and peripheral nerve models and this did not vary with age (Thayer et
al, 1990; Garyantes & Regehr, 1992; Benham et al, 1992; Griffith & Murchison, 1995;
Jasek & Griffith, 1998).
Vanadate (VO4'3*3
) is analogous to the transition state of phosphate (PO4' )
involved in enzyme reactions, allowing it to inhibit P-type ATPase’s (Smith et al., 1980;
Stankiewicz et al, 1995). Given vanadate’s similarity to the phosphate molecule, it is
logical to assume vanadate may affect other ATPases, phosphatases, and kinases. Weak
inhibition of phosphatase activity has been reported in cell cultures, red blood cells, and
rat spleen (Brunati & Pinna, 1985; Boivin et al., 1986; Imes et al., 1987). In contrast,
purified kinases exposed to vanadate showed no significant effect on pyruvate kinase,
creatine kinase, or inorganic pyrophosphatase (Boyd et al., 1985). Vanadate partially
blocks the Na+/K+-ATPase pump, thus possibly altering [Na+] and [K+] balance and in
turn basal [Ca2+]i (Cantley et al., 1977; Bond & Hudgins, 1979). However, despite only
a transient effect, vanadate had no sustained significant effect on basal [Ca ]i m young
or aged SCG cells, suggesting that blockade of Na+/K+-ATPase pumps does not
appreciably affect basal [Ca2+]i (Fig. 1C,D; Fig 3A,B). Furthermore, if these non
specific actions of vanadate did have an effect on other parameters of the calcium
transient, then these effects would be manifested in rate of rise and peak height. Our own
studies (Table 2) and studies in dorsal root ganglion neurons have shown no significant
effect of vanadate on peak [Ca2+]i (Benham et al., 1992). Therefore we may assume that
the effects of vanadate appear to be localized to Ca -ATPase systems, and the
“nonspecific” effects of this treatment were minimal in SCG cells.
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Complete [Na+]e replacement will remove the inward sodium gradient that drives
calcium efflux resulting in reversed exchange with calcium moving into the cell. The use
of TEA to replace [Na+]e had no significant effect on resting [Ca2+]i (Fig. 3A,B)>
suggesting that the Na+/Ca2+-exchanger is not critical in determining resting [Ca2+]i in
these cells, and that any calcium entry via the reverse process of the exchanger is easily
sequestered by other calcium buffering systems.

5.2

Impact ofAge on SERCA Function
In this study a differential sensitivity of PMC As and SERCAs to vanadate was

established. Our study confirms the K1/2 values cited by Salvador and Mata. In the low
vanadate concentration range (0.01 - 0.25 pM), our intent was to effectively block
PMCAs, while at higher vanadate concentrations (0.5 - 100 pM), blockade of both
PMCAs and SERCAs was expected. Indeed, in SCO cells from young animals, vanadate
produced a biphasic response in the rate of recovery and time to recovery of [Ca2+]i over
the entire concentration range. However, this was not the case in aged SCG cells, in
which vanadate only produced a single response over the same concentration range.
Vanadate had no further effect on aged SCG cells above a concentration of 0.25 pM, i.e.
after PMCA blockade, whereas in young animals there was an additional and significant
2-F

decline in rate of recovery and increase in time of recovery of [Ca ]i. Vanadate above
0.25 pM frequently induced calcium spikes in 6-month-old cells only (Fig. 1C,D; Fig.
3A,B). The calcium spikes are produced because blockade of SERCA uptake prevents
calcium sequestration, but not leakage, in calcium stores (Verkhratsky & Kettenman,
1996; Carlson et al., 1997). The greater effect of high vanadate on recovery dynamics of
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[Ca ]i-transients and inducement of calcium spikes in young cells as compared to aged
neurons is further evidence that SERCA function declines with age. These data
strengthen our previous work suggesting that an age-related decline in SERCA function
exists in SCG cells (Tsai et al., 1998).
One explanation for such a decline in SERCA function with age may be changes
in expression of SERCA isoforms. Indeed, SERCA mRNA expression declines with age
in cardiac tissue and pancreatic p-cells (Maciel et al, 1990; Varadi et al., 1996). In
another study, SERCA proteins in rat myocardium were shown to remain stable with age.
Despite unchanged SERCA content, 45Ca2+-uptake declined, which corresponded to a
decline in calmodulin mediated phosphorylation of SERCAs (Xu & Narayanan, 1998).
Thus, an age-related decline in function does not necessarily imply a decline in
expression of the protein. These data emphasize that other mechanisms underlying agerelated changes in the function of calcium buffering systems need to be explored with a
combination of functional and molecular tools.

5.3

Impact ofAge on PMCA Function
These studies underscore a larger issue. That is, during normal healthy aging,

alternative mechanisms can compensate for an age-related decline in a particular
component of the calcium buffering systems. In the low vanadate concentration range
(i.e. PMCA blockade), the effect of vanadate on rate of recovery and time to recovery of
[Ca2+]i was greater in SCG cells from 20-month-old animals compared to 6-months (Fig.
2). Furthermore, low vanadate concentrations ( < 0.5 pM) in the presence of
thapsigargin, which blocked the contribution of SERCAs, showed a significant effect on
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rate of recovery of [Ca2+]i in young SCG cells (Table 3). These data suggest that PMC A
function is maintained with age, however, the plasma membrane extrusion system
compensates for a deficiency in SERCA function. We hypothesized that when SERCA
calcium uptake declines with age, other calcium buffering components, such as PMCAs
may be able to compensate and restore [Ca2+]i to basal levels. Together, our data using
two different concentration ranges of the Ca2+-ATPase antagonist vanadate support the
hypothesis that in aged neuronal cells SERCA function declines and cells become more
dependent on PMCAs to control [Ca2+]i.

5.4

Dependence on Mitochondrial Calcium Uptake
Recently mitochondria have been established as an important participant in the

control of [Ca2+]i-transients (Werth et al., 1994; David et al., 1998; Pinton et al., 1998).
Therefore, we wished to investigate the impact of age on the ability of mitochondria to
buffer [Ca2+]i-transients when SCG cells are forced to rely on mitochondrial calcium
uptake. In the present study we found that, when PMCAs and SERCAs were blocked
with 100 pM vanadate and Na+/Ca2+-exchange was blocked by replacement of [Na+]e
with TEA, SCG cells could fully recover from high [K ]-evoked [Ca ]i-transients. In
addition, there was a significant decline in the recovery dynamics of [Ca2+]i in both 6and 20-month SCG cells, with no age-related difference. These data suggest that there is
2_|_

no age-related change in the ability of the mitochondria to control [Ca ]i-transients and
that mitochondria may also compensate for a decline in SERCA function.
Complementing these data, we have previously illustrated that the effect of the
mitochondrial calcium uptake blocker, dinitrophenol, was greater in 20-month-old SCG
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cells as compared to 6-month (Buchholz et al., 1996). Furthermore, mitochondria in
aged basal forebrain neurons compensate for increased calcium influx (Murchison et al.,
1998).
Our findings are in contrast to studies suggesting that mitochondrial calcium
uptake declines with age in hippocampal neurons (Vitorica & Satrustegui, 1986; Villalba
et al., 1995; Satrustegui et al., 1996). One explanation for this effect could be that these
studies were done in synaptosomes, instead of single cell preparations, and mitochondrial
calcium uptake was not directly measured. Instead, total 45Ca2+ release from
mitochondria was measured in the presence of the oxidative phosphorylation uncoupler,
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP). Release of mitochondrial
calcium may not accurately measure the activity of mitochondrial calcium uptake by the
Ca2+/H+-uniporter itself, but rather, may simply indicate a change in the capacity of
mitochondria to store calcium. The primary factor in mitochondrial calcium uptake is
maintenance of the mitochondrial proton gradient to provide electrochemical energy for
calcium uptake. Indeed, in rat liver microsomes and brain synaptosomes there is no
significant age-related change in the mitochondrial proton gradient, respiratory rate, or
membrane potential (Vitorica et al., 1985; Paradies & Ruggiero, 1991). Thus, these
studies support our data in SCG cells suggesting that the capacity of mitochondrial
calcium uptake is maintained with age.

In conclusion, we have provided data that support the hypothesis that advancing
age in SCG is associated with a significant decline in SERCA function, reinforcing the
importance of Ca2+-ATPase uptake and extrusion as a component of the neuronal calcium
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buffering system. Additionally, to compensate for the age-related decline in SERCA
activity, PMCA and mitochondrial function appear to be maintained with age and provide
ancillary calcium buffering capacity. Despite knowledge of the mechanisms involved in
neuronal [Ca ]i regulation, elucidation of the importance and participation of each
calcium buffering component is still lacking and additional studies are necessary to
confirm their roles in neuronal degeneration.
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1.

ABSTRACT
SERCA function declines with age in adrenergic nerves from the superior

cervical ganglion. In excitatory cells intracellular calcium ([Ca2+]i)-signals are
regulated by multiple calcium buffering mechanisms to restore [Ca2+]i to basal levels and
maintain [Ca2+]i homeostasis. The involvement of [Ca2+]i in multiple neuronal pathways
suggests that dysfunction of [Ca ]i homeostasis may be a primary mediator of agerelated neuronal degeneration. Previous work in sympathetic neurons supports the
hypothesis that a decline in sarco/ endoplasmic reticulum Ca -ATPase (SERCA)
function occurs with advancing age. To test for age-related functional changes in
SERCA activity, [K ]-evoked [Ca ]i-transients were measured by fura-2
microfluorometry in acutely dissociated superior cervical ganglion (SCO) cells from F344 rats. SCG cells were forced to rely on SERCAs by exposure to low vanadate (0.1
pM) to selectively block plasma membrane Ca2+-ATPase pumps, dinitrophenol (100 pM)
to block mitochondrial Ca -uptake, and replacement of [Na ]e with tetraethylammonium
to block Na+/Ca2+-exchange. Analysis of rate of recovery of [Ca2+]i showed a decline in
both young and old SCG cells with a greater effect in old animals. These findings
suggest that, when the calcium buffering system is forced to rely on SERCA Ca -uptake
to maintain [Ca2+]i homeostasis, calcium transients are affected to a greater extent in old
compared to young SCG cells.
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2.

INTRODUCTION
Calcium homeostasis in neurons involves multiple calcium buffering components

working in concert to restore stimulation-evoked intracellular calcium concentration
([Ca2+]i)-signals to basal levels (Kostyuk & Verkhratsky, 1994). After neuronal
'y i

excitation, the cell must quickly restore [Ca ]i to basal levels in order to reset the cell for
the next stimulus and avoid prolonged exposure to cytotoxic levels of high [Ca ]i
(Miller, 1991). Major components involved in neuronal calcium regulation include
calcium sequestration into the endoplasmic reticulum by sarco/endoplasmic reticulum
'y j

|

calcium ATPase (SERCA) pumps and into mitochondria by an electrophoretic Ca /H uniporter. Additional buffering mechanisms include a mobile group of cytosolic calcium
binding proteins, plasmalemmal calcium extrusion via plasma membrane Ca2_b -ATPase
(PMC A) and plasma membrane Na /Ca -exchange (Heizmann & Hunziker, 1991;
Rizzuto, Brini, Murgia & Pozzan, 1993; Carafoli, 1997; MacLennan, Rice & Green,
1997; Blaustein & Lederer, 1999). The SERCA pumps have a high affinity for calcium
ions and fast turnover rates (Lytton, Westlin, Burk, Shull & MacLenna, 1992), making
y|

yj

#

them essential for regulating stimulation-evoked [Ca ]i-signals to maintain [Ca ]i
homeostasis (Pozzan, Rizzuto, Volpe & Meldolesi, 1994; Tsai, Pottorf, Buchholz &
Duckies, 1998; Hussain & Inesi, 1999).
In central and peripheral neurons it is hypothesized that the aging process causes
multiple changes in the ability of neurons to regulate [Ca2+]i homeostasis (Duckies, Tsai
& Buchholz, 1995; Buchholz, Tsai, Foucart & Duckies, 1996; Michaelis et al, 1996;
Murchison & Griffith, 1999). Since intracellular calcium is a universal second messenger
integrating numerous cellular pathways, an age-related breakdown in mechanisms
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controlling [Ca2+]i homeostasis could contribute to neuronal degeneration (Gibson &
Peterson, 1987; Khachaturian, 1994; Thibault et al, 1998). One component of neuronal
calcium regulation believed to decline with age is the function of SERCA pumps.
Previous studies using microfluorometric measurements of [K ]-evoked [Ca ]i-transients
from rat superior cervical ganglion (SCG) cells have suggested an age-related decline in
SERCA function (Tsai, Hewitt, Buchholz & Duckies, 1997; Tsai et al, 1998; Pottorf,
Duckies & Buchholz, 2000). Other reports in dorsal root ganglion cells and skeletal
muscle also have shown declines in SERCA function with advancing age (Gafhi & Yuh,
1989; Kirischuk & Verkhratsky, 1996). In support of this decline in function, SERCA
mRNA expression in cardiac tissue and vascular smooth muscle and pancreatic p-cells
has also been shown to decline with age (Maciel, Polikar, Rohrer, Popovich & Dillmann,
1990; Lompre, 1999).
However, despite the age-related decline in SERCA expression and function, the
neuronal cell contains robust alternative calcium buffering mechanisms that can
compensate for a deficit in SERCA calcium uptake. The calcium buffering components
of mitochondrial sequestration and plasma membrane extrusion have been shown to
compensate for either an age-related decline in SERCA buffering capacity or an increase
in neuronal calcium influx (Buchholz et al, 1996; Tsai et al, 1998; Murchison &
Griffith, 1998). Nevertheless, even though neurons contain multiple backup systems to
control stimulation-evoked [Ca2+]i-transients and to maintain [Ca2+]i homeostasis, aged
neurons may still be highly vulnerable to calcium overload (Choi, 1992). Thus,
alternative buffering mechanisms may be able to compensate for decline in function of a
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single buffering component during normal function. However, under more stressful
conditions, it may become impossible to maintain [Ca ]i homeostasis.
To date, evidence for a decline in function of SERCA pumps has relied on
somewhat indirect approaches, since many different buffering mechanisms
simultaneously contribute to calcium homeostasis. Therefore we sought to isolate the
function of SERCA pumps from other calcium buffering components by blocking plasma
membrane Ca2+-ATPase (PMCA) pumps with vanadate, mitochondrial calcium uptake
with dinitrophenol (DNP) and Na+/Ca2+-exchange by replacement of extracellular sodium
([Na+]e) with tetraethylammonium (TEA). In the presence of these blockers SCO cells
are forced to rely primarily on SERCA pumps to regulate [K+]-evoked [Ca2+]i-transients.
Using this paradigm, we investigated the impact of age on the capacity of SERCA pumps
to control [K+]-evoked [Ca2+]i-transients in SCG cells from 6- and 20-month-old Fisher344 rats. If an age-related decline in SERCA function exists in aged animals, then we
would expect the ability of SERCAs to sequester calcium to be lower in SCG cells from
aged compared to young animals. Forcing SCG cells to rely on SERCA uptake to control
[Ca2+]i homeostasis, we sought for evidence that an age-related decline in function of
SERCA pumps occurs in sympathetic nerves.

3.

METHODS & MATERIALS

3.1

Experimental Animals
Male Fischer-344 (F-344) rats aged 6- and 20-months were obtained from the

NIH-NIA breeding colony (Harlan Sprague-Dawley, Inc., Indianapolis, IN). Animals
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took food and water ad libitum and were maintained on a 12 hr light/dark cycle under
controlled temperature (72 ± 2 °F).

3.2

Superior Cervical Ganglion Preparation
SCG cells were isolated by acute dissociation as previously described (Schofield,

1990). Briefly, rats were anesthetized with CO2 followed by decapitation. SCG were
dissected from the carotid artery bifurcation and placed in cold Tyrode’s solution
containing (in mM): NaCl, 150; KC1, 4; CaCb, 2; MgCb, 2; N-(2-hydroxyethyl)
piperazine-N’-2-ethanesulfonic acid (HEPES), 10; and glucose 10. The ganglia were
then acutely dissociated in 5 mL of Earle’s balanced salt solution (EBSS) containing:
trypsin (0.5 mg/mL; -6000 units/mL), collagenase D (1 mg/mL), DNAse-1 type IV (0.1
mg/mL), HEPES (20 mM), glucose (10 mM), and NaHCOs (10 mM), pH adjusted to 7.4
with NaOH. After incubation in a shaking water bath for 45 min at 34°C, the digestion
reaction was terminated by the addition of 5 mL of modified Hank’s balanced salt
solution (HBSS) with 10% fetal calf serum, CaCb (1.3 mM), and HEPES (5 mM), pH
adjusted to 7.4 with NaOH. The dissociated cells were then lightly pelleted at 600 rpm
(60 x g) for 5 min, the supernatant removed, pellet gently re-suspended in 5 mL of fresh
HBSS, and cells pelleted again at 600 rpm (60 x g) for 5 min. Cells were dispersed in 0.5
mL of HBSS onto Cell-Tak protein coated 22 mm glass coverslips (8 pg/slide) modified
by attaching a 2 cm Teflon ring to the surface with Sylgard. Coverslips were incubated
for 2 hr at room temperature to allow cell attachment to the Cell-Tak protein coat before
further treatment.
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3.3

Measurement of Intracellular Calcium
A dual wavelength ratiometric fura-2 microfluorimetry system was used to

measure [Ca2+]i in SCG cells. SCG cells were loaded with 10 jaM fura-2
acetoxymethylester (fura-2/AM) for 20 min at room temperature, then washed with 5 mL
of low [K+] (5 mM) buffer composed of (in mM): NaCl, 138; CaCli, 2; MgCh, 1; KC1,
5; HEPES, 10; glucose, 10; pH adjusted to 7.4 with NaOH. Incubation was continued for
an additional 30 min to allow intracellular esterases to convert the fura-2/AM dye into the
free acid form (Thayer, Sturek & Miller, 1988). Coverslips were mounted into a
superfusion chamber, which was attached to the stage of a Nikon inverted microscope
(Nikon Instruments, Tokyo, Japan). The microscope was attached to a Universal
Imaging System running MetaFluor version 3.0 (Universal Imaging Corporation, West
Chester, PA). The perfusion system allowed the chamber volume (~250 pL) to be
exchanged at the rate of 500 pL/sec (i.e. 2 times/sec). A suitable cell was distinguished
as a rounded cell body isolated from other cells with localized phase-contrast illumination
of the fura-2 probe. A mercury vapor lamp illuminated the fura-2 probe, and
fluorescence was excited alternately at wavelengths 340 and 380 nm by a Sutter-II
rotating filter wheel (Sutter Instrument Company, Novato, CA). The fura-2 emission
fluorescence at 510 nm was selected by a barrier filter and recorded by a CCD
Hamamatsu imaging camera (Hamamatsu Corporation, Bridgewater, NJ). Adjusting the
microscope stage to a point with no cells in the field of view and capturing a background
image before the start of the experiment corrected for background light levels. Prior to
fura-2/AM loading, cellular autofluorescence was examined in SCG cells.
Auto fluorescence was found to be undetectable by our imaging system and did not
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significantly alter our [Ca2+]i measurements. During the experiment, 340 and 380 images
were collected at a rate of 4 boxcar-averaged images/sec. These were corrected for
background fluorescence, calcium concentration calculated, and the data logged to a text
file. During dye loading and data collection, ambient light levels were minimized, and
neurons were only illuminated during data acquisition to minimize bleaching and
potential photo damage of the dye.
Intracellular calcium was estimated by both in vitro and in vivo calibration
methods. The in vitro method was performed using a calcium calibration kit (Molecular
Probes, Eugene, OR) with known [Ca2+] ranging from 0-40 pM. Each prepared
calcium solution was loaded with 4 pM fiira-2 pentapotassium salt. A droplet of each
[Ca2+] was placed onto a glass slide, the fluorescent intensities from 340 and 380
excitation were measured, and a curve of 340/380 ratio (R) versus [Ca ] was plotted.
Excitation of calcium solution at zero [Ca ] and recording of 340/380 ratio and 380 nm
fluorescence intensities for 1 min allowed for the determination of Rmm and Fmjn,
respectively. Replacing the calcium solution with 40 pM [Ca2+] and recording
fluorescence intensities revealed Rmax and Fmax values.
The in vivo method was performed on SCG cells by decreasing extracellular
calcium concentration to 0 mM to determine Rmin and Fmin. Replacing the extracellular
94-

medium with 10 mM [Ca ] with ionomycin (1 pM) and depolarizing with high
potassium (68 mM) gave Rmax and F max- The values for Rmin, Fmin, Rmax, and Fmax were
remarkably similar between the in vitro and in vivo methods. Our in vitro calibration for
Kd is comparable to in vivo values previously reported in neuronal cells (Neher, 1995;
Murchison & Griffith, 1998). We applied the same Kd for both young and old SCG
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neurons, since previous reports have shown no significant difference in fura-2 K<i values
for young and old neurons (Murchison & Griffith, 1998).
Since our in vitro method correlated well with in vivo measurements, the values
obtained from the in vitro calibration were used to convert the experimental fluorescence
intensity ratios (R) to [Ca2+] over the physiological range of [Ca2+]i by iterative fit to the
equation:
R-R min
[Ca2+]i = Kd [j
max I!

Sf

Rmin is the 340/380 ratio at zero [Ca2+] and Rmax is the 340/380 ratio at 40 pM [Ca2+].
The value of Kd is the dissociation constant of fura-2, while Sf is a correction factor
relating the ratio Fmin/Fmax, which represents emission intensities at 380 nm when fura-2
is in the free (Fmm; 0 pM [Ca2+]) or bound (Fmax; 40 pM [Ca2+]) form (Grynkiewicz,
Peonie & Tsien, 1985). For this report, [Ca ]i was estimated using averaged in vitro
values for Sf (7.6), Rmin (0.33), Rmax (2.75), and Kd (251 nM).

3.4

Experimental Protocol
To assess the function of SERCAs in young and old sympathetic neurons, SCG

cells were first depolarized (SI, control) for 15 sec by superfusion with Tyrodes buffer
containing 68 mM KC1 followed by a wash out with low [K+] (5 mM) buffer and a 2 min
equilibration period. Cells were then exposed to a low concentration of vanadate (0.1
pM) to preferentially block PMCAs (Salvador & Mata, 1998; Pottorf et al, 2000) and
allowed to equilibrate for 1 min. Next, dinitrophenol (DNP, 100 pM) was added to
remove the contribution of mitochondrial calcium uptake, and cells were allowed to
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equilibrate for 3 min in the presence of both vanadate and DNP. Finally, zero sodium
([Na+]e replaced with TEA) was added to block the function of Na+/Ca2+-exchangers, and
SCG cells were depolarized (S2) for 15 sec in the presence of 68 mM KC1, 0.1 pM
vanadate, 100 pM DNP and zero sodium.

3.5

Data Analysis
The resting [Ca2+]i for SCG cells was recorded as a long segment (50 - 60 sec) of

fluorescence ratio signal before initial depolarization of the cell. The peak change in
[Ca2+]i was measured by subtracting the baseline (or resting) [Ca2+]i from the peak
[Ca2+]i. The baseline [Ca2+]i was measured as the mean [Ca2+]i 2-5 sec immediately
before each [Ca2+]i transient. Rate of rise of [Ca2+]i (nM/s) was determined by measuring
from baseline [Ca2+]i to peak [Ca2+]i. The rate of recovery of [Ca2+]i (nM/s) was
measured from the peak change in [Ca2+]i to within 90% recovery to baseline. The rates
of rise and recovery of [Ca2+]i were determined by linear fit regression (mean r values of
0.973 and 0.972, respectively).

3.6

Statistical Analysis
The effect of vanadate/DNP/TEA treatment on calcium transients within age

groups was analyzed by paired Student’s /-test. The effect of age on the response of
calcium transients to treatment with vanadate/DNP/TEA was analyzed by unpaired
Student’s /-test or two-way ANOVA with Fischer-PLSD test. Data are presented as
mean ± SEM.
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94-

blockers significantly increased the time to recovery of [Ca ]i by 100% in young SCG
cells and by 170% in aged SCG cells as compared to control values (Fig. 2B). As shown
in figure 2, both of these effects of treatment with vanadate, DNP, and zero Na+ were
significantly greater in cells from old compared to young animals.

4.3

Basal [Ca2+]i measurements
Acutely dissociated SCG cells prepared from 6- and 20-month-old rats showed a

stable basal [Ca ]i that was indistinguishable between the age groups (6 month: 99 ± 4
nWL,N= 30 and 20 month: 102 ± 3 nM, A= 21). Basal [Ca2+]i levels 1 min after washout
of high [K+] remained elevated in both 6- and 20-month-old SCG cells compared to
before exposure to high [K+]; however, there was no significant difference between the
age groups (Fig. 3). Application of low concentrations of vanadate (0.1 pM) to block the
94-

function of PMC As produced no significant change in basal [Ca ]i in either young or old
SCG cells. However, exposure of SCG cells to DNP (100 pM), a mitochondrial calcium
94-

uptake blocker, produced a significant and sustained increase in basal [Ca ]i in cells
from aged animals (Fig. 3). In cells from young animals, addition of DNP produced a
transient rise in basal [Ca2+]i which was not sustained. After recovery from high [K+]depolarization in the presence of vanadate, DNP, and zero Na+, basal calcium levels
remained elevated. The increase in basal [Ca ]i was significant in both 6- and 20month-old SCG cells compared to control basal levels; however, there was no significant
difference with age (Fig. 3).
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Figure 1. Representative tracings of the effects of vanadate, dinitrophenol, and zero Na+ on [K+]evoked [Ca2+]i-transients in SCO cells from (A) 6 and (B) 20-month-old rats. Effects of addition
of vanadate (0.1 pM Va), dinitrophenol (100 pM DNP) and zero Na+ (replaced with TEA) are
shown. Figure insets (i, ii) illustrate rate of recovery of [Ca2+]i after [K+]-evoked depolarization
of control (SI) and treated (S2) cells with an expanded time scale to resolve changes in recovery.
Rate of recovery was analyzed by best fit linear regression with mean r values of 0.970 for
control and 0.969 for treated [Ca2+]i-transients. Fura-2 loaded cells were depolarized (Control,
SI) for 15 sec with Tyrodes buffer containing 68 mM [K+], followed by a 2 min equilibration.
Cells were then exposed to 0.1 pM Va for 1 min. Next, DNP (100 pM) was added and cells
allowed to equilibrate for 3 min in the presence of Va and DNP. Finally, [Na+]e was removed
(Na+ replaced with TEA) and SCO cells depolarized (Va/DNP/Zero Na+) for 15 sec in the
presence of Tyrodes buffer containing 68 mM KC1, Va, DNP and zero Na+ followed by a 2 min
equilibration.
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Figure 2. Effect of treatment with vanadate (Va), dinitrophenol (DNP), and zero Na+ (Na+
replaced with TEA) on rate of recovery and time to recovery of [Ca2+]i in 6- and 20-month-old
SCG cells. (A) Rate of recovery of [Ca2+]i was determined by linear regression analysis from
peak [Ca2+]i level to 90% of basal [Ca2+]i. (B) Time to recovery was determined by the
difference in time from peak [Ca2+]i to 90% of basal [Ca2+]i. Freshly isolated SCG cells loaded
with fura-2 were depolarized (Control) for 15 sec with Tyrodes buffer containing 68 mM [K+],
followed by a 2 min equilibration. Cells were then exposed to low concentrations of Va (0.1 pM)
for 1 min. Next, DNP (100 pM) was added and cells allowed to equilibrate for 3 min in the
presence of Va and DNP. Finally, [Na+]e was removed and SCG cells depolarized
(Va/DNP/Zero Na+) for 15 sec in the presence of Tyrodes buffer containing 68 mM KC1, Va,
DNP and zero Na+ followed by a 2 min equilibration. Differences between control and
Va/DNP/Zero Na+ treatment were determined by two-way ANOVA with repeat measures and
Fisher-PLSD test or unpaired Student’s Mest. * = significantly different from control,/? < 0.05.
+ = significantly different from 6-month-old SCG cells,/? < 0.05. N= 30 cells from twelve, 6month-old animals and 21 cells from twelve, 20-month-old animals.
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Figure 3. Effect of age on basal [Ca2+]i in the presence and absence of calcium uptake blockers
in SCG cells. Basal [Ca2+]i was recorded in fura-2 loaded cells for 1 min prior (Control) and 1
min following each treatment. Effects of treatments were determined by two-way ANOVA with
repeat measures and Fisher-PLSD test or unpaired Student’s t-test. * = significantly different
from control,/? < 0.05. + = significantly different from 6-month-old SCG cells,/? < 0.05. N= 30
cells from twelve, 6-month-old animals and 21 cells from twelve, 20-month-old animals.
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5.

DISCUSSION

5.1

Technical Considerations
The use of fluorescent calcium sensitive probes can introduce potential sources of

error, which merit discussion (Moore, Becker, Fogarty, Williams & Fay, 1990; Kao,
1994; Neher, 1998). The [Ca2+]i values we report are estimates and not absolute values.
Therefore, comparison of age-related changes in calcium buffering relies on relative
differences in [Ca2+]i between the two age groups. Within each age group,
depolarizations of each cell under treated conditions are paired with control stimulations
94-

9-1-

for the same cell. Resting [Ca ]i, peak [Ca ]i, and the rates of rise and recovery
(nM/sec) reported are well within the accepted physiological ranges reported in neurons
and other cells (Neher, 1995; Murchison & Griffith, 1998). In the present experiments,
peak [Ca2+]i transients are typically below 1.0 pM [Ca2+]i. Therefore, peak [Ca2+]i
transients fall within the linear range (0.02 - 2.0 pM [Ca ]) of the in vitro calibration
curve for fura-2. Additionally, there appears to be little evidence of incomplete
hydrolysis or compartmentalization of the fura-2/AM dye (Zhou & Neher, 1993). The
short loading time and low concentration of fura-2/AM combined with low temperature
and long de-esterification time minimizes these possible sources of error.
It has been suggested that the cell dissociation process may differentially affect
fiira-2 loading for young and aged SCG cells and may be responsible for our observed
age-related effect. When cells are at rest, the 380 run signal is a comparative indicator of
fura-2 loading (Negulescu & Machen, 1990). The 380 run signals are remarkably similar
between young and old SCG cells (6 month: 89.27 ± 2.57; 20 month: 90.72 ± 3.53 F380,
emission intensity of fura-2 excited at 380 run). This strongly suggests that the cell
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dissociation process does not introduce a sampling artifact, compromise data, or alter
fiira-2 loading in SCG cells. Our basal [Ca ]i levels are comparable with values
reported in central and peripheral nerve models, and these do not vary with age (Thayer
& Miller, 1990; Garyantes & Regehr, 1992; Benham, Evans & McBain, 1992; Griffith &
Murchison, 1995; Jasek & Griffith, 1998).
Ortho vanadate (VOT3) inhibits P-type ATPase’s and is similar to the transition
state of phosphate (PO4") involved in enzyme reactions (Smith, Zinn & Cantley, 1980;
Stankiewicz, Tracey & Crans, 1995). The similarity of vanadate to phosphate may affect
other ATPases, phosphatases, and kinases. In cell cultures, red blood cells, and rat spleen
vanadate produces weak inhibition of phosphatase activity (Brunati & Pinna, 1985;
Boivin, Galand & Bertrand, 1986; Imes, Kaplan & Knowles, 1987). In contrast, after
exposure to vanadate there was no significant effect on the activity of purified forms of
pyruvate kinase, creatine kinase, or inorganic pyrophosphatase (Boyd, Kustin & Niwa,
1985). Vanadate can also partially block the Na+/K+-ATPase pump, thus possibly
affecting [Na+] and [K+] balance and in turn basal [Ca2+]i (Cantley et al., 1977; Bond &
Hudgins, 1979). However, exposure of young and aged SCG cells to vanadate had no
significant effect on basal [Ca2+]i, suggesting that blockade of Na+/K+-ATPase pumps
does not appreciably affect basal [Ca ]i in our cell model (Fig. 2; Pottorf et al., 2000).
Other studies in dorsal root ganglion and SCG neurons have also shown no significant
effect of vanadate on peak [Ca2+]i (Benham et al., 1992; Pottorf et al, 2000). Therefore,
these data suggest that the effects of vanadate are localized to Ca2+-ATPase systems, and
that “nonspecific” effects of this treatment were minimal in SCG cells.
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Mitochondrial calcium uptake blockers like DNP, carbonyl cyanide chlorophenyl
hydrazone (CCCP), ruthenium red, and antimycin used to disrupt Ca2d- -uptake can
potentially affect other cellular processes. However, the application of DNP to resting 6month-old SCG cells produced only a transient rise in [Ca ]i that returned to basal levels
even with continued presence of the mitochondrial blocker (Fig. 1 A; Fig. 2). Other
9-1-

studies also showed only a transient rise in [Ca ]i when CCCP was applied to dorsal root
ganglion cells (Werth & Thayer, 1994). These data suggest that the mitochondria contain
very little sequestered calcium when neuronal cells are at rest. Only when the neuronal
cell is depolarized do we observe the full effect of mitochondrial calcium blockade,
94-

which produces large increases in peak [Ca ]i in dorsal root ganglion and SCG cells
(Buchholz et al., 1996; Werth, Usachev & Thayer, 1996).
Complete [Na+]e replacement will remove the inward sodium gradient that drives
calcium efflux resulting in reversed exchange with calcium moving into the cell. The Km
of the Na+/Ca2+-exchanger is approximately 2 pM (Reeves & Sutko, 1979). Therefore, it
is thought that the exchanger is primarily responsible for regulating large calcium loads
and less important in adjusting small loads and resting [Ca ]i levels in neurons of dorsal
root ganglion and SCG cells (Benham et al., 1992; Werth et al., 1996; Pottorf et al.,
2000). Additionally, in our SCG cell model the use of TEA to replace [Na+]e had no
significant effect on resting [Ca2+]i (Fig. 2), suggesting that the Na+/Ca2+-exchanger is
not critical in determining resting [Ca ]i in these cells.
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5.2

Function of SERCA Calcium Uptake with Age
The focus of this study was to investigate the impact of age on [Ca2.A~ ]i•

homeostasis when SCG cells were forced to rely on SERCA pumps to restore [K+]evoked [Ca2+]i-transients back to basal levels. SCG cells from young and old animals
exposed to vanadate (0.1 pM), DNP (100 pM) and [Na+]e replaced with TEA could
restore [K+]-evoked [Ca2+]i-transients to levels close to basal. Exposure to these blockers
resulted in a significant decline in the recovery phase of [Ca ]i in both age groups, but
there was clearly a greater effect in cells from old compared to young animals. The agerelated decline in calcium recovery could not be attributed to age-related differences in
sensitivity to the calcium blocking agents, since the increase in basal [Ca2+]i in the
presence of these blockers was the same for both age groups, except in the presence of
vanadate and DNP (Fig. 3). Therefore, these findings suggest that the function of
SERCAs declines with advancing age.
Previous studies investigating age-related changes in SERCA function used the
approach of applying selective SERCA blockers, such as thapsigargin or cyclopiazonic
acid. For example, in isolated rat SCG cells, microfluorometric measurements of [K+]evoked [Ca2+]i-transients showed a significant decline in the rate of calcium recovery in
the presence of SERCA blockade in young SCG cells, but no significant change in old
cells (Tsai et al., 1998). Further evidence of an age-related change in SERCA function
was observed when noradrenaline release was measured in rat tail arteries in the presence
of these same SERCA blockers, showing an increase in stimulation-evoked noradrenaline
release in young arteries with no change in arteries from old animals (Tsai et al, 1998).
Therefore, current data underscore conclusions from our previous work with selective
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SERCA blockers, indicating a decline in SERCA function with advancing age in
autonomic nerves (Tsai et al, 1998; Pottorf et al., 2000).

5.3

Compensation for Declines in SERCA Function with Age
Selective SERCA blockers have been used to provide evidence for a decline in

SERCA function with advancing age. However, blockers of other buffering components
have shown a greater contribution to intracellular calcium regulation in older cells,
presumably due to a deficit in calcium regulation by SERCAs. Since each component of
the [Ca2+]i buffering system contributes to the regulation of stimulation-evoked [Ca2+]itransients and maintenance of [Ca ]i homeostasis in neurons, dysregulation of [Ca ]i
homeostasis by the impairment of one of these components has the potential to increase
the functional contribution of other calcium buffering mechanisms. Thus one or more
calcium buffering mechanisms may prevent adverse effects by compensating for a
decline in function by another component.
It has been demonstrated in several neuronal cell types that mitochondrial calcium
uptake takes on a crucial role in compensating for alterations in calcium regulation with
advancing age. In acutely dissociated neurons of rat SCG, addition of mitochondrial
I

24- •

calcium uptake blockers resulted in a greater effect on high [K ]-evoked [Ca ]itransients in old (20 month) compared to young (6 month) animals (Buchholz et al.
1996). In basal forebrain neurons, activation of voltage-gated calcium channels by
voltage clamp techniques resulted in an age-related increase in calcium influx; however,
simultaneous microfluorometric analysis of [Ca ]i levels also revealed a decline in peak
[Ca2+]i (Murchison & Griffith, 1998). When rat basal forebrain neurons were exposed to
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CCCP and [Ca2+]i-transient elicited by caffeine, there was a significantly greater increase
in peak [Ca2+]i in neurons from old compared to young animals (Murchison & Griffith,
1999). These data suggest a greater dependence upon mitochondrial calcium uptake
when a component of the calcium regulatory system fails to restore stimulation-evoked
[Ca2+]i-transients back to basal levels. The greater dependence upon mitochondria to
compensate for changes in calcium regulation correlates with the increased sensitivity of
basal [Ca2+]i to the presence of DNP in SCG cells from 20-month-old animals (Fig. 3).
The role of plasma membrane extrusion systems (PMCA and Na+/Ca2+-exchange)
have been highlighted as important participants in the dynamic regulation of [Ca ]itransients and as crucial players in calcium extrusion (Carafoli & Stauffer, 1994; Werth et
al., 1996; Blaustein & Lederer, 1999). In rat aortic endothelial cells, there is believed to
be interdependence between PMCA and SERCA gene expression. This was tested by
blocking of SERCAs with thapsigargin, which resulted in an increased level of mRNA
expression of PMCAs with concurrent increases in PMCA protein levels (Kuo et al,
1997). In another study, levels of SERCA and Na+/Ca2+-exchange proteins were
correlated with force-frequency relations in ventricular muscle strips from failing human
myocardium (Hasenfuss et al, 1999). A decreased diastolic function was correlated with
decreased SERCA protein levels; however, ventricular strips showing compensated
diastolic function demonstrated increased expression of Na /Ca -exchange protein levels
apparently to compensate for declines in SERCA function. These studies reveal that
when [Ca ]i homeostasis is compromised, redundant calcium buffering mechanisms
exist that can compensate for a decline in function of another component.
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5.4

Possible Mechanisms of Age-Related Decline in SERCA function
To date the mechanisms responsible for age-related declines in SERCA function

have not been identified; however, there are several possibilities to account for a decline
in SERCA function with advancing age. One obvious possibility would be that there is a
decline in levels of mRNA expression for one or more SERCA isoforms, translating into
decreased levels of SERCA protein. Indeed, SERCA mRNA expression in several cells
types has been shown to decline with age (Maciel et al, 1990; Varadi et al., 1996;
Lompre, 1999). However, age-related declines in SERCA mRNA expression could not
be correlated with levels of SERCA protein in rat skeletal muscle or myocardium
(Ferrington et al., 1997; Xu & Narayanan, 1998). These studies have been repeated in rat
cerebral cortex, which also show an age-related decline in SERCA mRNA expression,
but no corresponding change in protein levels (Pottorf, De Leon, Hessinger, Buchholz;
unpublished data).
Despite unchanged SERCA protein levels, an age-related decrease in 45Ca2+uptake into microsomes has been observed in rat myocardium. This reduction in calcium
uptake was suggested to be the result of age-related declines in calcium/calmodulin
kinase (CAMK) protein expression and the ability of CAMK to phosphorylate SERCAs
(Xu & Narayanan, 1998). It has also been suggested that the effectiveness of the
calmodulin dependent activation of CAMK in rat brain synaptic membranes declines
with advancing age (Zaidi, Gao, Squier & Michaelis, 1998). Such effects would manifest
as an age-related decline in phosphorylation of SERCA and could result in depressed
SERCA function. Still another group has proposed that in rat skeletal muscle SERCA
molecules are more prone to undergo self-association to form inactive oligomers with
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advancing age (Ferrington et al, 1997). These studies suggest possible mechanisms of
calcium regulation, independent of changes in SERCA mRNA and protein levels, which
may be sensitive to the aging process and could account for observed age-related declines
in SERCA function. Further studies are necessary to elucidate which mechanisms are
responsible for age-related declines in SERCA function.

In conclusion, these studies document a significant reduction in the function of
SERCA pumps in SCG cells with advancing age. Neuronal dysregulation of [Ca ]i
homeostasis is suggested to be a critical factor in age-related neuronal degeneration
(Gibson & Peterson, 1987; Khachaturian, 1994; Thibault et al, 1998). Therefore, a
decline in SERCA function with age could lead to altered [Ca2+]i regulation and may
ultimately contribute to calcium overload in neurons. Although an age-related decline in
SERCA function appears to occur in SCG cells, other calcium buffering mechanisms are
2_j_

.

2d" *

able to compensate for a deficit in [Ca ]i homeostasis in order to restore basal [Ca ]i
and prevent calcium overload (Tsai et al, 1997; Tsai et al, 1998; Pottorf et al, 2000).
The exact mechanism responsible for an age-related decline in SERCA function has not,
as yet, been identified; however, there are several possibilities. Despite current
knowledge of the mechanisms involved in neuronal [Ca2+]i regulation, understanding of
the importance and participation of each calcium buffering component is still lacking,
and additional studies are needed to confirm the role of each separate component in
[Ca2+]i dysregulation with advancing age.
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1.

ABSTRACT
Effect of aging on function and expression of SERCA in rat cerebral cortex.

Calcium acts as a second messenger in biological systems to integrate numerous cellular
pathways. Previous work in sympathetic neurons suggests that a decline in
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) function occurs with advancing age.
Therefore, an age-related breakdown in the mechanisms controlling intracellular calcium
homeostasis could contribute to altered neuronal function and/or neuronal degeneration.
In this study we sought to determine age-related changes in SERCA function and
expression in rat cerebral cortex from young (6-month) and old (20-month) animals.
Functional studies compared ATP-dependent, oxalate-facilitated 45Ca2+-uptake into
microsomes and plasma membrane vesicles (PMV) with advancing age. For both
microsomal (thapsigargin-sensitive) and PMV (thapsigargin-insensitive) fractions, there
was no significant difference in 45Ca2+-uptake with age. Expression studies measured
SERCA3 mRNA and protein content in rat cerebral cortex in young and old animals. Old
animals showed a significant decline in SERCA3 mRNA levels compared to young.
However, comparison of SERCA3 protein content did not reveal a corresponding decline
with advancing age; therefore, implying that SERCA turnover rates are greater in young
animals. Although the present work with rat cerebral cortex does not indicate an agerelated decline in SERCA function or content, previous work from our laboratory with
sympathetic nerves suggests that such a decline does exist. In comparison to studies in
peripheral neurons our present study on central neurons suggest fundamental differences
in the ways aging affects critical calcium homeostatic mechanisms in central and
peripheral autonomic neurons.
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2.

INTRODUCTION
The free intracellular calcium content of neuronal cells at rest consists of only a

small fraction of the total cellular content of calcium (1/10,000th), including that which is
buffered and sequestered (Blaustein, 1988). In neuronal cells the level of free
intracellular concentration ([Ca2+]i) is fastidiously regulated by multiple calcium
buffering mechanisms to maintain [Ca ]i between 100 - 200 nM (Nachshen, 1985;
9+

Ashley, 1986; Hartmann, Eckert & Muller, 1994). Upon neuronal excitation the [Ca ]i
rapidly increases and the calcium buffering system quickly reacts to restore [Ca ]i to
basal levels in preparation for the next stimulus (Nachshen, 1985; Fontana & Blaustein,
1993; Ghosh & Greenberg, 1995). However, prolonged exposure of neurons to elevated
[Ca2+]i causes calcium cytotoxicity and possible neurodegeneration (Choi, 1992, 1994).
Because high [Ca2+]i can be damaging or fatal to mature neurons, powerful
regulatory mechanisms exist to attenuate [Ca2+]i-transients and restore [Ca2+]i to resting
levels (Kostyuk & Verkhratsky, 1994). The primary components involved in
intracellular calcium regulation in neurons include calcium sequestration into the
endoplasmic reticulum by sarco/endoplasmic reticulum Ca -ATPases (SERCA) pumps
and into the mitochondria by electrophoretic Ca /H -uniporters. Secondarily, calcium
buffering mechanisms include cytoplasmic calcium binding proteins, plasmalemmal
calcium extrusion via plasma membrane Ca2+-ATPases (PMCA), and Na+/Ca2+-exchange
(Carafoli, 1997; Heizmann & Hunziker, 1991; Rizzuto, Brini, Murgia & Pozzan, 1993;
MacLennan, Rice & Green, 1997; Blaustein & Lederer, 1999). In a concerted fashion
these diverse calcium buffering systems attenuate [Ca ]i-transients and maintain resting
[Ca2+]i.
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The SERCAs actively accumulate two calcium ions into the endoplasmic
reticulum for each hydrolyzed ATP molecule (MacLennan, 1970). Three different genes
encode the SERCAs and alternative splicing produces five different isoforms (Wuytack
et al., 1992). The SERCAla (adult) and lb (fetal) isoforms are exclusively found in
skeletal muscle. The SERCA2a is found in both skeletal and heart muscle and the
SERCA2b and 3 are found in the endoplasmic reticulum of brain and several other cell
types (Wu, Lee, Wey, Bungard & Lytton, 1995). Although the SERCA isoforms belong
to the same gene family, they are diverse in structure, function, and sensitivity to
pharmacological agents (Lytton, Westlin, Burk, Shull & MacLennan, 1992).
Increasing evidence suggests that the control of [Ca2+]i in some central and
peripheral neurons is altered with advancing age (Duckies, Tsai & Buchholz, 1995;
Buchholz, Tsai, Foucart & Duckies, 1996; Michaelis et al, 1996; Tsai, Hewitt, Buchholz
& Duckies, 1997; Tsai, Pottorf, Buchholz & Duckies, 1998; Murchison & Griffith, 1999).
An age-related change in calcium homeostasis could contribute to changes or loss of
function, and possibly neuronal degeneration (Gibson & Peterson, 1987; Khachaturian,
1994; Thibault et al, 1998).
In peripheral sympathetic neurons, microflourometric measurements of [K+]evoked [Ca2+]i-transients from rat superior cervical ganglion (SCG) cells strongly
implicate an age-related decline in SERCA function (Tsai et al, 1998; Pottorf, Duckies &
Buchholz, 2000). Uptake measurements of 45Ca2+ by microsomes isolated from dorsal
root ganglion cells and skeletal muscle also reveal age-related declines in SERCA
function (Gafni & Yuh, 1989; Kirischuk & Verkhratsky, 1996). However, the
mechanism of the age-related decline in SERCA function is not yet known.
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3.2

Isolation ofMicrosomes and Plasma Membrane Vesicles
Microsomes and plasma membrane vesicles (PMV) were prepared by the method

of Salvador and Mata (1998) with minor modifications. Briefly, rats were anesthetized
with CO2 followed by decapitation. Whole brains were removed from the cranial cavity
and the cerebral cortex collected, minced, and placed in 5 ml of fresh homogenizing
buffer (Buffer A) contained (in mM): HEPES (10), sucrose (320), MgSCU (0.5),
phenylmethylsulfonyl fluoride (0.25), and adjusted to pH 7.4 with KOH. Tissues were
homogenized using 10-15 passes with a motorized glass-Teflon homogenizer at 4°C.
Homogenates were centrifuged for 15 min at 2000 x g to pellet cellular debris. The
supernatant fraction (SN-I) was transferred to a new sterilized tube and centrifuged for 30
min at 20,000 x g to obtain a new pellet (P-II) and supernatant fraction (SN-II). PMV
(enriched with PMCAs) were prepared from the P-II fraction by re-suspending in 1 ml of
Buffer A, aliquoting, and storing at -80°C. The SN-II fraction was transferred to a new
tube and further centrifuged for 75 min at 100,000 x g to obtain a final pellet (P-III).
Microsomes (enriched with SERCAs) were prepared by re-suspending the P-III fraction
in 0.5 ml Buffer A, aliquoting, and storing at -80°C. Protein concentration was
determined by the colorimetric method (Smith et al., 1985) using a bicinchoninic acid
(BCA) protein assay kit (Pierce Chemical) with bovine serum albumin (BSA) as a
standard. The assay was measured spectrophotometrically at 570 nm using a Bio-Rad
microplate reader, model 3550.
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3.3

Calcium Uptake Assay
Calcium uptake was determined by ATP-dependent, oxalate-facilitated uptake of

45Ca2+ by microsomes and PMV isolated from 6- and 20-month rat cerebral cortex using
the Millipore filtration technique as described by Narayanan (1981). The assay medium
(pH 7.2) contained (in mM): HEPES (50), KC1 (100), MgCl2 (3.5), NaCl (20), Na2ATP
(5), potassium oxalate (1), and ruthenium red (0.025). Ruthenium red, a mitochondrial
calcium uniporter blocker, was added to block the effect of possible mitochondrial
contamination in microsomal and PMV fractions. The medium was thermo-equilibrated
with 5 pM 45CaCl2 (2000 mCi/mmol) for 5 min at 37°C. Adding 25 pg of microsomes or
PMV initiated the reaction, which was then incubated at 37°C for incubation times of 0.5
10 min. For assays selectively blocking SERCAs, the pre-incubation medium
contained thapsigargin (0, 0.1 or 5.0 pM) and microsomes or PMV incubated for 10 min
at 37°C. Calcium uptake was terminated by filtering 50 pi aliquots of each sample
through HAWP Millipore filters (0.45 pm pore size, 25 mm diameter) followed by an
immediate 10-ml wash with ice-cold buffer (50 mM HEPES, 100 mM KC1, 3.5 mM
MgCl2, 20 mM NaCl, pH 7.2). The filters were washed an additional 4x with 10-ml of
ice-cold buffer. Filters were then transferred to scintillation vials, dried for 30 min at
40°C, and 10 ml of scintillation cocktail added to each vial. Radioactivity was
determined by liquid-scintillation spectrometry. Appropriate controls for assays without
membranes (Blank) and without ATP (Control) were included for each experiment.
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3.4

Northern Blot Analysis
Isolation of RNA and Northern blot analysis were performed on young and old rat

cerebral cortex using the modified protocol of De Leon et al. (1991). Briefly, tissues
from rat cerebral cortex were minced, homogenized in a glass-Teflon homogenizer, and
total RNA collected by a guanidium thiocyanate/phenol/chloroform precipitation method
(Chomczynski & Sacchi, 1987). The collected RNA was dried using a Speed Vac
(Labconco, Model 78120-00) and then dissolved in 0.5% sodium dodecyl sulfide (SDS).
Total RNA samples (20 pg/well) were separated by electrophoreses in a 1% agaroseformaldehyde gel at constant voltage (100 mV) for 150 min. The gel was then soaked in
10X sodium/saline phosphate/EDTA (SSPE) for 45 min and then RNA transferred to
nylon membrane (Hybond-N, Amersham Pharmacia Biotech) with 10X SSPE for 3 hr
(10X SSPE = 1.5 M NaCl, 0.1 M NaH2P04, 0.01 M EDTA). Heating at 80°C for 30 min
dried the membrane and then RNA was affixed to membrane by UV cross-linking (Fisher
Scientific SB-UVXL 1000). Membranes were pre-hybridized at 37°C for 1 hr with 10 ml
of Express-Hyb solution (Clontech Laboratories). A 50-mer oligonucleotide probe
corresponding to nucleotides 707 - 756 (5’ - tgccattccagacccccgagccgtgaaccaggacaagaag
aacatgctgt - 3’) of the SERCA3 rat cDNA (Burk, Lytton, MacLennan & Shull, 1989) was
synthesized and used to determine the relative SERCA3 mRNA expression in RNA
samples of rat cerebral cortex from young and old animals. The selective SERCA3
oligonucleotide probe (10 pmol) was labeled with [a-32P]dATP (3000 Ci/mmol) using a
3’-end DNA labeling kit with terminal transferase (Boehringer-Mannheim). The labeled
probe was purified from unincorporated nucleotides by separating on a Chroma-Spin-30
size exclusion column (Clontech Laboratories). The probe was diluted in 10 ml of fresh

140

Express-Hyb solution (final activity 107 cpm/ml) and allowed to hybridize with the
membrane for 1 hr at 37°C. After hybridization, membranes were washed 3X for 15 min
each with 2X sodium/saline citrate solution (SSC) + 0.05% SDS at 25°C followed by
washing 3X for 15 min each with 0.5X SSC + 0.1% SDS at 35°C (2X SSC = 0.15 M
NaCl, 0.015 M sodium citrate). The membrane was then exposed to Kodak X-OMAT
AR x-ray film (Eastman Kodak) at -70°C for 3 to 6 hr. Densitometeric analysis of
autoradiographic films was analyzed to determine relative SERCA3 mRNA expression
with age. The SERCA3 mRNA level in each lane was standardized to cyclophilin
mRNA expression using a 0.7-kb rat cyclophilin cDNA probe.

3.5

Western Blot Analysis
Western immunoblotting techniques were used to detect and measure the relative

amounts of SERCA3 isoform protein in young and aged rat cerebral cortex using a
modified protocol of Lytton et al. (1992). Microsomal samples were prepared in
Laemmli sample buffer containing 5% 2-mercaptoethanol (Laemmli, 1970). Protein
samples were heated for 5 min at 95°C, loaded onto a 7.5% Tris-HCl precast SDS
polyacrylamide gel (Bio-Rad), and then separated under constant voltage (200 mV) for
60 min in a Mini-Protean electrophoresis module (BioRad). Proteins were transferred
onto polyvinyldiene difluoride (PVDF) membranes by electroblotting with a semi-dry
transfer cell (BioRad Laboratories) at room temperature for 30 min at constant voltage
(15 V). Completion of electroblotting was verified by staining the gel with Coomasie
blue to show absence of residual protein. Detection of SERCA3 isoform protein was
performed by initially blocking membranes overnight at 4°C in phosphate buffered saline
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(PBS, pH 6.9) containing 1.0% nonfat dried milk (w/v) and 0.1% Tween-20. The next
day, the blocking buffer was poured off and replaced with the polyclonal (rabbit) primary
anti-SERCA3 IgG antibody diluted 1:1000 in PBS/Tween-20. Incubation of membranes
with primary antibody continued for 3 hr at room temperature. The primary antibody
was removed and membranes washed 3X for 5 min each with PBS/Tween-20. The
membranes were then incubated for 1 hr at room temperature with horseradish peroxidase
(HRP) conjugated to secondary anti-rabbit IgG antibodies diluted to 1:2000 in
PBS/Tween-20. After incubation the secondary antibody was poured off and the
membranes washed 3X for 5 min each with PBS/Tween-20. Protein bands were detected
by exposing membranes to enhanced chemiluminescence detection solution (ECL+;
Amersham Pharmacia Biotech) for 2 min followed by autoradiography (Hyperfilm ECL;
Amersham Pharmacia Biotech) for 10 min. Several protein concentrations (5-75 pg)
were used from both age groups for comparing SERCA3 protein content with age.
Densitometeric analysis of autoradiographic films was used to determine relative protein
content with age.

3.6

Data Analysis
45Ca2+-uptake values were generated by converting counts per min (cpm) to nmol

calcium and then expressed as uptake activity (nmol/pg protein). Control assays were
performed with microsomal and PMV fractions in the absence of ATP, while blank
assays contained ATP but did not contain membrane fractions. Experiments were done
in duplicate and corrected values (control subtracted) were averaged.
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Relative band density of Western and Northern blots was determined using a
ChemiNova CCD camera connected to an imaging system (Chemilmager, Alpha
Innotech Corporation) running Chemilmager 4000 software (version 3.3).
Densitometeric values were given as integrated density values (IDV) with the area of
measurement within each band remaining constant. Each Western blot exhibited multiple
protein concentrations from both age groups. For instance, protein amounts (in pg) of 5,
10, 25, 50, and 75 for both age groups were run in parallel on the same gel as a relative
comparison of band density with age. Western blots for each age group were performed
in triplicate and values averaged together. The molecular weight of the target protein
(SERCA3, -97.4 KDa) was determined by running molecular weight standards with the
following markers: myosin (220 KDa) from rabbit muscle, phosphorylase b (97 kDa)
from rabbit muscle, and albumin (66 KDa) from bovine serum. For each Northern blot,
samples were run in duplicate and values averaged together. Differences in sample
loading were corrected for by determining the level of cyclophilin mRNA expression for
each age group as an internal standard, which has been shown to be maintained with age
in neurons (lacopino & Christakos, 1990; Kuchel, Rowe, Meaney, & Richard, 1997).
Determination of SERCA3 and cyclophilin mRNA bands were compared with a RNA
molecular weight ladder with RNA range of 0.24 - 9.5 kb.

3.7

Statistical Analysis
Data presented in results are expressed as mean ± SEM. Statistical significance

was determined by unpaired Student’s t-test or two-way ANOVA with Fischer-PLSD
test. Ap< 0.05 was accepted as the level of significance.

143

4.2

Effects ofAge on Calcium Uptake into Microsomal and PMV Fractions
The time-courses of ATP-dependent, oxalate-facilitated Ca -uptake into

microsomes and PMV isolated from 6- and 20-month-old rat cerebral cortex were
2“h

compared (Fig. 1 A, B). For both microsomal and PMV fractions, the extent of Ca uptake increased linearly with time. There was, however, no significant difference
between 6- and 20-month rats. Rate of calcium uptake detected by least-squares
comparison of the slope over the entire range of incubation times showed no significant
2+

difference between 6- and 20-month animals (Table 2). The amount of Ca -uptake at 10
min was greater in microsomes (-2800 nmol/pg) compared to PMV (-550 nmol/pg)
(Fig. 1). Calcium uptake plateaued at incubation times greater than 10 min for both
microsomes and PMV with no significant difference with age (data not shown).

COMPARISON OF CALCIUM UPTAKE IN MICROSOMAL AND PLASMA MEMBRANE
VESICLE FRACTIONS FROM RAT CEREBRAL CORTEX

Microsomes
(enriched with SERCA)
(nmol/|!g/min)

Plasma Membrane Vesicles
(enriched with PMCA)
(nmol/fig/min)

6 Month

247 ±34

51.4 ± 5.8

20 Month

244 ± 48

49.0 ± 1.9

Table 2. Values represent mean ± SEM. Values were generated by least-squares comparison of
calcium uptake (nmol/pg) to incubation time (min) and converted to the slope value (nmol/pg/min) and
averaged together. Values were compared by unpaired Student’s Mest. N= 6 experiments with
microsomes and V= 4 experiments with PMV, repeated in duplicate. Microsomal and PMV fractions
isolated from rat cerebral cortex were prepared from six, 6-month and six, 20-month-old animals.
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4.3

Sensitivity ofMicrosomal Fractions to Thapsigargin with Advancing Age
The sensitivity of microsomal fractions to thapsigargin was assessed with

advancing age. In microsomes, 0.1 pM thapsigargin decreased Ca -uptake by ~40% in
2_|_

both age groups (Fig. 2). Little further decline in Ca -uptake occurred when
thapsigargin was increased to 5 pM. Maximal blockade of 45Ca2+-uptake by thapsigargin
only approached ~50%, suggesting the presence of a thapsigargin-insensitive component
of calcium uptake. Since the microsomes were insensitive to low concentrations of
vanadate (Table 1), the likelihood of the thapsigargin-insensitive calcium uptake being
due to contamination by PMCAs is minimal.

4.4

Aging Effects on SERCA3 mRNA Expression in Rat Cerebral Cortex
The expression of the SERCA3 mRNA isoform was identified in cerebral cortex

from 6- and 20-month-old rats using an oligonucleotide probe derived from the SERCA3
rat cDNA (Burk et al., 1989). The probe identified a single 4.5 kb RNA band in both 6and 20-month animals (Fig. 3A). The SERCA3 mRNA content of rat cerebral cortex
from old animals was significantly lower than from young animals (Fig. 3B). Agerelated changes in SERCA3 expression was normalized with cyclophilin mRNA as an
internal control (lacopino & Christakos, 1990; Kuchel et al, 1997). Cyclophilin
expression appeared to be the same in both age groups (Fig. 3A,B)- Comparison of
SERCA3 to cyclophilin mRNA expression in rat cerebral cortex revealed a significant
age-related decline of-25% in cyclophilin-normalized SERCA3 mRNA content from
aged compared to young animals (Fig. 3C).
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4.5

SERCA3 Protein Expression with Advancing Age
Age-related changes in SERCA3 protein levels were examined by Western

immunoblotting of microsomes isolated from rat cerebral cortex for 6- and 20-month
animals. A polyclonal anti-SERCA3 IgG antibody was used to probe for the SERCA3
isoform (Lytton et al., 1992; Wuytack et al, 1994). A single band at 97 kDa occurred in
both age groups corresponding to the SERCA3 protein isoform (Fig. 4A). The relative
amounts of SERCA3 protein in rat cerebral cortex was linear over the range 5-75 pg of
microsomal protein (Fig. 4B). Analysis by least squares fit revealed no age-related
difference in slope values of SERCA3 protein level versus total protein in microsomes
isolated from rat cerebral cortex (6-month, 1.71 ± 0.09; 20-month, 1.74 ± 0.13 integrated
density value/pg total microsomal protein). Thus, there was no significant age-related
difference in SERCA3 protein levels.
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Figure 1. Calcium uptake in microsomes and plasma membrane vesicles (PMV) isolated from 6and 20-month-old rat cerebral cortex. 45Ca2+-uptake was initiated by the addition of 25 pg of
microsomes (A) or PMV (B) in the presence of ATP (5 mM), oxalate (1 mM) and ruthenium red
(25 pM). The assays were incubated for the times indicated at 37°C. 45Ca2+-uptake values
represent nmol Ca27pg protein - control, but are expressed as nmol/pg for simplification.
Control assays are determined by the amount of 45Ca2+-uptake by microsomes or PMV in the
absence of ATP. Data shown represent mean ± SEM. Comparison of Ca2+-uptake with age was
determined by unpaired Student’s /-test. No statistical significant difference was observed in
Ca2+-uptake in microsomes or PMV with age,/> >0.05. Experiments with microsomes (N= 6)
and with PMV (N= 4) were repeated in duplicate. Microsomal and PMV samples were prepared
from individual rat cerebral cortex from six, 6-month and six, 20-month-old animals.
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Figure 2. Sensitivity of calcium uptake to thapsigargin in microsomes. Microsomes isolated
from rat cerebral cortex were incubated for 10 min at 37°C in the presence and absence of
thapsigargin (0, 0.1, 5 pM). Measured 45Ca2+-uptake values are corrected for control values and
then expressed in normalized form as “percent of control.” Maximum Ca2+-uptake (Control) was
determined from the amount of uptake by microsomes or PMV in the absence of thapsigargin.
All assays were corrected for by the amount of Ca2+-uptake by microsomes or PMV in the
absence of ATP. Data shown represents mean ± SEM. * = significantly different from control,
p < 0.05. Comparison of Ca2+-uptake with age was determined by unpaired Student’s /-test. N =
3 experiments with microsomes and vV= 3 experiments with PMV, repeated in duplicate.
Microsomal and PMV samples isolated from rat cerebral cortex were prepared from six, 6-month
and six, 20-month-old animals.
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Figure 3. (A) Representative Northern blot of SERCA3 mRNA expression in rat cerebral cortex
isolated from 6- and 20-month-old animals. (B) Estimation of the relative amounts of SERCA3
and cyclophilin mRNA expression in rat cerebral cortex from 6- and 20-month-old animals. (C)
Comparison of SERCA3/cyclophilin mRNA ratios with advancing age. The SERCA3 mRNA
was probed using a selective 50-mer oligonucleotide probe correlating to positions 707 - 756 of
the SERCA3 rat cDNA. SERCA3 and cyclophilin mRNA sizes were determined by the position
of the RNA markers. Variance in RNA loading was corrected for by the level of cyclophilin
expression as an internal standard. Autoradiograms were analyzed by densitometry and band
density was reported as integrated density values (IDV) with the area around each band remaining
constant. Data presented are given as mean ± SEM. Significance was determined by unpaired
Student’s Ctest. * = significantly different from 6-month,/> < 0.05. Data presented in B & C
represent A = 12 Northern blots with RNA samples done in duplicate for each age group. RNA
samples isolated from rat cerebral cortex were prepared from six, 6-month and six, 20-month
animals.
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Figure 4. (A) Representative Western blot of SERCA3 protein expression in rat cerebral cortex
isolated from 6- and 20-month-old animals. (B) Estimation of the relative amounts of SERCA3
protein expression in rat cerebral cortex from 6- and 20-month-old animals. A protein
concentration range (5-75 pg total protein) was separated by SDS-PAGE and transferred to
PVDF membrane. A polyclonal anti-SERCA3 IgG antibody was used to selectively probe for
SERCA3 isoform protein. SERCA3 molecular weight was determined by the position of the
standardized protein markers. Autoradiograms were analyzed by densitometry and band density
was reported as integrated density values (IDV) with the area around each band remaining
constant. Data presented are given as mean ± SEM. Significance was determined by unpaired
Student’s /-test. No statistical significant difference was observed in SERCA3 protein expression
with age, p > 0.05. Data presented represents A = 4 Western blots with each protein
concentration paired between age groups and blots performed in triplicate. Microsomal samples
isolated from rat cerebral cortex were prepared from four, 6-month and four, 20-month-old
animals.
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5.

DISCUSSION

5.1

Effects of SERCA Blockade on Calcium Uptake into Microsomal and PMV
Fractions with Advancing Age
Our previous studies, and those from other groups, have shown an age-related

decline in SERCA function in peripheral sympathetic neurons and in myocardial and
skeletal muscle. In this study we sought to determine if an age-related decline in SERCA
function is also manifested in central nervous tissue. Therefore, we focused on possible
age-related changes in SERCA-mediated calcium uptake into microsomal membranes
from neurons of the cerebral cortex.
The ATP-dependent 45Ca2+-uptakes by microsomal and PMV fractions isolated
from young (6-month) and old (20-month) cerebral cortex were not significantly
different. The selective SERCA blocker, thapsigargin, significantly inhibited calcium
uptake in microsomal fractions (enriched with SERCAs) at 0.1 pM in both age groups
(Fig. 2). However, in PMV factions (enriched with PMCAs), thapsigargin did not
significantly inhibit calcium uptake, even at the maximal concentration of 5 pM (Table
1). The insensitivity of PMV fractions to thapsigargin suggests that isolated PMVs from
rat cerebral cortex are primarily enriched with PMCAs and that SERCA contamination is
minimal. Conversely, the higher sensitivity of the microsomal fraction to thapsigargin
indicates that this subcellular fraction contains a higher content of SERCAs compared to
PMV fractions.
Although an age-related change in calcium uptake was not observed in
microsomes isolated from rat cerebral cortex, our previous microfluorometric studies in
superior cervical ganglion (SCG) cells indicate an age-related decline in SERCA activity
(Tsai et al, 1998; Pottorf et al, 2000). The selective SERCA blocker, cyclopiazonic acid
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(5 (jM), caused a significant decline in the recovery phase of [K+]-evoked [Ca2+]itransients in SCG cells from young animals with no effect in cells from old animals (Tsai
et aL, 1998). Vanadate concentrations greater than 1 pM, which will also antagonize
I

*

SERCAs, also caused a significant decline in rate of recovery of [K ]-evoked [Ca ]itransients in young with no effect in SCG cells from old animals (Pottorf et al, 2000).
These studies suggest that in peripheral autonomic neurons there is an age-related decline
in the function of SERCAs. Similarly, in other peripheral neurons and excitable tissues
calcium uptake by SERCAs has also been shown to decline. For example, in microsomes
isolated from rat skeletal muscle and myocardium calcium uptake via SERCAs declined
with age (Narayanan, 1981; Gafni & Yuk, 1989; Xu & Narayanan, 1998). In addition, a
decline in SERCA function has been suggested to be responsible for more prolonged
calcium transients in dorsal root ganglion cells (Kirischuk & Verkhratsky, 1996). Thus,
in peripheral neurons and muscle tissues there seems to be mounting evidence that the
functional capacity of SERCAs declines with age.
Since SERCA function appears to decline in peripheral excitable cells, it may be
tempting to suggest that an age-related decline in SERCA function occurs in all neurons.
However, caution is warranted in making such a generalization, as the present study and
those of other investigators suggest. Interestingly, two studies reported an age-related
increase in thapsigargin-sensitive calcium uptake in whole rat brain microsome (Hanahisa
& Yamaguchi, 1998; Yamaguchi et al, 1999). In the first study, an increase in SERCA
activity with age was, in part, related to enhanced protein kinase C activity (Hanahisa &
Yamaguchi, 1998). Protein kinase C is involved in the regulation of SERCA activity and
9-1-

the data showed that staurosporine, a protein kinase C antagonist, decreased Ca -ATPase
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activity in brain microsomes from aged rats, but did not affect activity in microsomes
from young animals (Hanahisa & Yamaguchi, 1998). In the second study, the expression
of regucalcin with advancing age was monitored since regucalcin appears to negatively
modulate SERCA activity. With advancing age the expression of regucalcin declined,
thus, attenuating inhibitory modulation of SERCAs (Yamaguchi et al., 1999). Data from
both of these studies suggest that there may be subtle age-related alterations in the
regulation of SERCAs that may, in effect, preserve or maintain SERCA activity in some
central neurons. Contrasting studies, with respect to calcium buffering in central and
peripheral neurons, underscore the need for caution in suggesting universal mechanisms
causing age-related changes in SERCA function.
Thapsigargin, even at high concentrations (5 pM), did not completely inhibit
45Ca2+-uptake by microsomal fractions (Fig. 2). Failure of thapsigargin to completely
inhibit calcium uptake in microsomes isolated from rat or pig brain has also been noted
by other investigators (Kijima, Ogunbunmi & Fleischer, 1991; Salvador & Mata, 1998;
Wells & Abercrombie, 1998). Several possibilities may explain this. Firstly, microsomal
fractions may be contaminated with other calcium translocating systems. However,
vanadate, which selectively blocks PMCAs below 0.25 pM (Salvador & Mata, 1998),
does not alter calcium uptake in our microsomal fraction (Table 1). These data are
consistent with the conclusion that our microsomal fraction was not significantly
contaminated with PMCAs. Secondly, thapsigargin-resistant, ATP-dependent
mechanisms capable of sequestering calcium may exist in some cell and microsomal
preparations (Waldron, Short & Gill, 1995; Pizzo, Fasolato & Pozzan, 1997). Indeed in
the presence of cyclopiazonic acid (500 pM), 2,5-di(terAbutyl)-l,4-benzohydroquinone

157

(1.5 mM), or orthovanadate (2 jaM), pig brain microsomes retain ~25% of 45Ca2+-uptake
(Salvador & Mata, 1998). Thirdly, the incomplete blockade of microsomal calcium
uptake could be due to the differential sensitivity of the SERCA isoforms to thapsigargin.
In one study, COS-1 cells, in which the four major SERCA isoforms (1, 2a, 2b, 3) were
overexpressed, were used to provide microsomes for measuring oxalate-facilitated, ATPdependent calcium uptake (Lytton, Westlin & Hanley, 1991). Overexpressed SERCA3
isoform was less sensitive to thapsigargin (80% blockade) than SERCA1, 2a, and 2b
isoforms (90-95% blockade). Since neuronal tissue primarily contains SERCA3 and 2b
isoforms, the rat cerebral cortex used in our present study may include a higher ratio of
SERCA3 to 2b isoform; thereby, resulting in thapsigargin-insensitive calcium uptake in
isolated microsomes.

5.2

SERCA3 mRNA Expression in Rat Cerebral Cortex with Advancing Age
To obtain additional information regarding molecular regulation of SERCAs, we

examined mRNA expression of the SERCA3 transcript in rat cerebral cortex from young
and old animals. Northern blot analysis revealed a 4.5 kb band in both young and old
animals corresponding to the SERCA3 mRNA isoform from previous reports with brain
tissues (Burk et al., 1989; Wu et al, 1995). Comparing SERCA3 mRNA levels with
cyclophilin levels, as an internal control, we demonstrated a significant decline in the
SERCA3 mRNA with advancing age (Fig. 3C). To the best of our knowledge, this is the
first reported age-related change in SERCA mRNA expression in central neurons. Other
studies have investigated age-related changes in SERCA expression in rat cardiac tissue
and vascular smooth muscle (Maciel et al., 1990; Lompre, 1999). These studies have
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also revealed a significant age-related decline in the mRNA expression of SERCAs. The
SERCA3 isoform also decreases in pancreatic p-cells in diabetes (Varadi, Molnar,
Ostenson & Ashcroft, 1996), and in the myocardium of failing heart (Hasenfuss et al.,
1994; Peters et al., 1997). Thus, it appears that a decline in SERCA mRNA expression
may commonly accompany aging and disease in various tissues.
Information regarding the regulation of SERCA mRNA expression is limited, but
it can be affected by hormones, growth factors, and [Ca2+]i levels (Simonides et al, 1996;
Kuo et al, 1997; Tajima et al, 1998) Additionally, SERCA mRNA is downregulated
when the PMCA gene is overexpressed in rat aortic endothelial cells, suggesting an
interdependency between PMCA and SERCA gene expression (Liu, Xu, Fridman,
Muallem & Kuo, 1996). Although the link between PMCA and SERCA regulation may
be calcium itself, the means by which calcium affects PMCA or SERCA gene expression
has yet to be elucidated (Ghosh & Greenberg, 1995).

5.3

Absence ofAge-Related Changes in SERCAS Protein Levels
To determine whether age-related declines in SERCA3 mRNA expression (Fig. 3)

reflect a decrease in SERCA protein or a decline in SERCA turnover, we measured
protein levels of the same isoform in rat cerebral cortex. SERCA3 protein levels
remained the same in both age groups (Fig. 4). Therefore, in rat cerebral cortex the
observed age-related decline in SERCA3 mRNA expression did not coincide with a
decrease in SERCA protein levels nor a decline in SERCA activity. This has also been
observed in rat skeletal muscle and myocardium (Ferrington et al, 1997; Xu &
Narayanan, 1998). In these studies, SERCA protein levels did not show a corresponding
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age-related change as predicted from measurements of mRNA expression. Additionally,
myocardial SERCA protein levels were compared between patients with terminal heart
failure and individuals with no signs of heart disease (Munch et al, 1998). In heart
failure, SERCA protein levels did not show a parallel decline compared to mRNA
expression even though a decline in SERCA function existed. Together, these studies
suggest that declines in SERCA mRNA expression in peripheral tissues and central
neurons do not necessarily correlate to declines in SERCA protein levels. Therefore,
age-related declines in [Ca ]i regulation by SERCAs, as observed by us in peripheral
neurons, may be due to changes in the function or regulation of SERCAs rather than due
to changes in gene expression.
Although declines in SERCA mRNA expression do not seem to be reflected by
corresponding changes in SERCA protein levels, there is often observed an age-related
decline in SERCA function. An age-related decline in rat myocardial microsomal
calcium uptake correlated with declines in calcium/calmodulin kinase (CAMK) protein
expression and in the ability of CAMK to phosphorylate SERCAs (Xu & Narayanan,
1998). Also, calmodulin-dependent activation of CAMK in rat brain synaptic
membranes declines with advancing age and may depress SERCA function via declines
in the ability of CAMK to phosphorylate SERCA pumps (Zaidi, Gao, Squier &
Michaelis, 1998). Others have proposed that SERCAs in rat skeletal muscle form
inactive oligomers with advancing age (Ferrington et al, 1997). Thus, in peripheral
neurons and tissues there may exist age-sensitive mechanisms of calcium regulation,
independent of changes in SERCA mRNA and protein levels, which account for declines
in SERCA function.
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In conclusion, the mechanism of possible age-dependent changes in brain [Ca ]i
regulation is still unresolved. Although our measures of SERCA mRNA and protein
levels are in agreement with studies in peripheral tissues, we did not observe an agerelated decline in brain SERCA function as we have observed in isolated SCG neurons
(Tsai et al., 1998; Pottorf et al., 2000). Indeed, age-related declines in SERCA function
appear to be restricted to peripheral excitable tissues. Thus, it seems possible that
SERCA function in peripheral neurons and other excitable tissues is more sensitive to
aging than that of central neurons.
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1.

INTRODUCTION

Descriptions of aging often assume an undesirable process:
‘Nothing is more dishonorable than an old man, heavy with years, who
has no other evidence of his having lived long except his age. ’
Seneca (B.C. 3-65 A.D.).

However, the process of aging does not have to be met with disdain:
‘If wrinkles must be written upon your brows, let them not be written upon
the heart. The spirit should not grow old. ’
James Garfield (1831-1881).

The statements above reflect the conundrum of the aging process. The first
statement suggests that as one ages, deterioration of a once energetic and youthful image
is all that remains after the inhospitable process of aging. Thus, many students of the
aging process have assumed a general deterioration of all cellular processes resulting in
increased susceptibility of the organism to pathology. The second statement is one of
hope. Many elderly individuals have weathered the aging process quite well, maintaining
remarkable peripheral physiological function and mental acuity. Despite much work on
this problem, however, the impact of the aging process on the function of central and
peripheral neurons remains a mystery in many respects (Verkhratsky & Toescu, 1998).
One facet of cellular function that has come to the forefront, in studies of the
impact of advancing age on neuronal function, is the involvement of the ubiquitous ion,
calcium. One prominent theory is that, in neurons, the aging process leads to
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dysregulation of calcium homeostasis (Duckies, Tsai & Buchholz, 1995; Michaelis et al.,
1996; Murchison & Griffith, 1998, 1999). Given that calcium appears to be a universal
second messenger in neurons, altered calcium homeostasis with age has been suggested
to be a fundamental mediator of age-related changes in neuronal function (Gibson &
Peterson, 1987; Khachaturian, 1994; Thibault et al, 1998).
The idea that altered calcium homeostasis with advancing age is responsible for
an age-related change in neuronal function is currently quite popular. However, despite
the attraction of this idea, evidence of altered calcium regulation in central and peripheral
neurons is difficult to sort out. For example as detailed below, studies have shown
declines in calcium buffering with advancing age in peripheral and some central neurons.
However, despite possible declines in any one component or multiple components of the
calcium buffering system, compensatory mechanisms seem to be able to maintain overall
calcium homeostasis. It remains to be seen whether similar changes also occur in other
types of nerves.

2.

SUMMARY OF DISSERTATION FINDINGS
This investigation of alterations in neuronal calcium buffering components with

advancing age led to four major findings. First, calcium imaging and norepinephrine
release studies revealed a decline in SERCA function to regulate calcium loads with
advancing age (Tsai, Pottorf, Buchholz & Duckies, 1998; Pottorf, Duckies & Buchholz,
2000b, 2000c). Each component of [Ca ]i regulation functions to modulate stimulationevoked [Ca ]i-signals in neuronal cells; therefore, an age-related impairment of any one
94-

component, such as SERCA, has the potential to affect [Ca ]i homeostasis. Second,
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although there appears to be a decline in function of SERCA with advancing age,
compensatory mechanisms such as PMCA, mitochondria and Na /Ca -exchange are
2_i_

mobilized to attenuate [Ca ]i-transients in spite of the loss of a major component of the
calcium buffering system (Buchholz, Tsai, Foucart & Duckies, 1996; Pottorf et al.,
2000b). The existence of multiple calcium buffering components allow for compensation
when one or more components are compromised. Therefore, with advancing age the
remaining calcium buffering components become a critical part of maintaining calcium
homeostasis and preventing calcium overload and excess neurotransmitter release in
neurons. Third, in rat cerebral cortex there is an age-related decline in the mRNA
expression of SERCA3 isoform; however, this decline did not translate to corresponding
age-related changes in SERCA3 protein content (Pottorf, De Leon, Hessinger &
Buchholz, 2000a). Although this seems rhetorical to have a decline in mRNA expression
without a parallel shift in protein content, this phenomenon is reproduced in several other
tissues with advancing age (Maciel, Polikar, Rohrer, Popovich & Dillmann, 1990;
Ferrington et al, 1997; Xu & Narayanan, 1998; Lompre, 1999). Fourth, 45Ca2+-uptake
into microsomes isolated from rat cerebral cortex revealed no age-related change in
calcium uptake or sensitivity to thapsigargin (Pottorf et al, 2000a). The consensus on
calcium uptake into microsomes is not clear, with measurements of decreased, increased,
or no change in calcium uptake with advancing age in neuronal tissue (Kirischuk &
Verkhratsky, 1996; Yamaguchi, Hanahisa & Murata, 1999; Pottorf et al, 2000a).
Although an age-related change in calcium uptake was not observed in microsomes
isolated from central nerves of rat cerebral cortex, our microfluorometric studies of
peripheral nerves from rat superior cervical ganglion (SCG) cells suggest such a decline
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in SERCA activity does exists. Contrasting studies, with respect to calcium buffering in
central and peripheral neurons, underscore the need for caution in suggesting universal
mechanisms causing age-related changes in SERCA function. The exact mechanism
responsible for an age-related decline in SERCA function has not, as yet, been identified;
however, there are several possibilities that remain to be investigated. Determination of
the mechanism responsible for regulation of SERCA and the other calcium buffering
components may provide the evidence necessary in understanding declines in [Ca2+]i
regulation with advancing age.

3.

DISCUSSION

3.1

Mechanisms ofIntracellular Calcium Regulation
Neurons and other excitable cells use calcium as a second messenger to integrate

numerous cellular pathways; these include neuronal development and maturation, gene
expression, synaptic plasticity, transmitter release, excitability, and cell death (Malenka,
Dauer, Perkel & Nicoll, 1989; Choi, 1992; Berridge, 1995, 1998; Clapham, 1995; Ginty,
^ i

t

1997; Spitzer & Ribera, 1998). In neurons intracellular calcium ([Ca ]i) homeostasis
relies on multiple calcium buffering components working in concert to restore
stimulation-evoked [Ca ]i-signals to basal levels (Kostyuk & Verkhratsky, 1994). After
neuronal excitation, the cell must quickly restore [Ca ]i to basal levels in order to reset
the cell for the next stimulus and avoid prolonged exposure to cytotoxic levels of high
[Ca ]i (Miller, 1991). Neurons utilize several calcium buffering components to regulate
[Ca ]i. These include calcium sequestration into the endoplasmic reticulum by
sarco/endoplasmic reticulum calcium ATPase (SERCA) pumps and into mitochondria by
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an electrophoretic Ca2+/H+-uniporter. Additional buffering components include a mobile
group of cytosolic calcium binding proteins, plasmalemmal calcium extrusion via plasma
membrane Ca2+-ATPase (PMCA), and plasma membrane Na+/Ca2+-exchange (Heizmann
& Hunziker, 1991; Rizzuto, Brini, Murgia & Pozzan, 1993; Carafoli, 1997; MacLennan,
Rice & Green, 1997; Blaustein & Lederer, 1999).

3.2

Loss ofBuffering Capacity with Advancing Age
The overall consensus is that there is a prevailing age-related decline in the ability

of neuronal cells to control stimulation-evoked [Ca2+]i-transients and to maintain [Ca2+]i
homeostasis (Gibson & Peterson, 1987; Khachaturian, 1994; Thibault et al, 1998). Such
a loss of calcium regulation could lead to alterations in neurotransmitter release with
advancing age (Mattson, Rydel, Lieberburg & Smith-Swintosky, 1993). One neuronal
system that has consistently been shown be functionally altered with advancing age is the
adrenergic innervation of the cardiovascular system. An age-related rise in systemic
blood pressure and increased levels of plasma catecholamines has repeatedly been
demonstrated in humans and laboratory animals (Palmer, Ziegler & Lake, 1978; Esler et
al, 1981; Barnes, Rashkind, Gumbrecht & Halter, 1982). Therefore, investigations were
begun to explore the impact of age on function of vascular adrenergic nerves.
Interestingly, an age-related increase in stimulation-evoked norepinephrine release from
rat vascular adrenergic nerves was actually found (Buchholz & Duckies, 1990).
Additional investigations demonstrated that this could not be accounted for by changes in
norepinephrine content, the function of neuronal or extraneuronal uptake mechanisms, or
the function of prejunctional oc2-adrenergic receptors (Buchholz & Duckies, 1990;
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Buchholz, Tsai, Friedman & Duckies, 1992). Therefore, investigations ensued to explore
the possibility that there is a fundamental age-related change in the process of regulation
of stimulation-evoked transmitter release in vascular adrenergic nerves.
3.2.1
•

i

Enhanced calcium buffering. To test whether alterations in

•

•

9-1-

norepinephrine release result from age-related changes in [Ca ]i homeostasis, the
calcium chelator, l,2-bis(2-aminophenoxy)ethane-A^A^Ar,,A^’-tetraacetatic acid (BAPTA),
was applied to determine if norepinephrine release would be attenuated when calcium
buffering capacity was augmented. Addition of BAPTA was more effective at reducing
stimulation-evoked norepinephrine release in older rat tail arteries compared to arteries
from young animals (Table 1; Tsai, Hewitt, Buchholz & Duckies, 1997). These data
suggest that there is an age-related reduction in calcium buffering capacity from
adrenergic nerves. However, as discussed above, there are multiple components involved
in the regulation of [Ca ]i and any one component alone or several components together
could be affected with advancing age. Therefore, multiple mechanisms involved in
[Ca ]i regulation were investigated to determine which components of the [Ca ]i
buffering system are affected by the aging process.

3.3

Effects ofAge on the Function of SERCAs
3.3.1

Blockade of SERCAs. One factor in calcium dysregulation with age in

vascular adrenergic nerves does appear to be a decline in the function of SERCAs.
Studies in autonomic nerves using the selective blockers thapsigargin and cyclopiazonic
acid suggest declines in SERCA function with advancing age. In isolated rat superior
cervical ganglion (SCG) cells, microfluorometric measurements of [K+]-evoked [Ca2+]i-
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transients in the presence of these SERCA blockers showed a significant decline in the
rate of calcium recovery in young cells but no significant change in calcium recovery in
old cells (Table 1; Tsai et al, 1998). Further evidence of an age-related change in
SERCA function was observed when norepinephrine release was measured in the
presence of the same SERCA blockers. Blockade of SERCAs caused an increase in
stimulation-evoked norepinephrine release in young rat tail arteries but there was no
effect of SERCA blockade in arteries from old animals (Table 1; Tsai et al, 1998).
These data suggest that SERCA uptake plays an important primary role in modulating
[Ca2+]i-transients in adrenergic nerves from young animals, while the function or
contribution of calcium uptake by SERCAs appears to be lost in nerves from old animals.
3.3.2 Reliance on SERCAs. The contribution of SERCA function with age was
further assessed by blocking all calcium buffering components except SERCAs in order
to force the system to rely primarily on endoplasmic reticulum calcium uptake to control
increased [Ca2+]i (Pottorf et al, 2000c). Acutely dissociated SCO cells from young and
old rats were exposed to vanadate (0.1 pM) to selectively block PMCA and dinitrophenol
(100 pM) to block mitochondrial calcium uptake, and [Na+]e was replaced with
tetraethylammonium (TEA) to block Na /Ca -exchange. Acutely dissociated SCO cells
were then depolarized by high [K+], and recovery of [Ca2+]i back toward basal levels was
monitored (Table 1; Pottorf et al, 2000c). Exposure of SCG cells to these blockers
resulted in a significant decline in the recovery phase of [Ca2+]i in both age groups
compared to control. However, there was clearly a greater effect of this treatment in cells
from old compared to young animals (Table 1). Thus when forced to rely primarily on
SERCAs, cells from old animals were not able to recover from increases in [Ca2+]i as
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well as cells from young animals. Therefore, these data, together with studies using
selective blockers of SERCAs, support the conclusion that there is a decline in SERCA
function with advancing age in adrenergic nerves (Tsai et al, 1998).

•

“h

2+ •

During blockade of SERCA function the recovery phase of [K ]-evoked [Ca ]itransients is extended. However, intracellular calcium is still restored to basal levels in
neuronal cells from both young and old animals. This finding suggests that
compensatory mechanisms are mobilized to attenuate the [Ca2+]i-transients in spite of the
loss of a major component of the calcium buffering system in nerves from aged animals.
Each component of the neuronal [Ca ]i buffering system contributes to the regulation of
stimulation-evoked [Ca ]i-transients and maintenance of [Ca ]i homeostasis. Therefore
2+

dysregulation of [Ca ]i homeostasis by impairment of any one of these components can
lead to an increase in the functional contribution of other calcium buffering components.
Thus one or more calcium buffering components may prevent adverse effects by
compensating for a decline in function by another component. This leads to the question:
Which component(s) of the calcium buffering system might compensate when a deficit in
2_i_ .

.

[Ca ]i homeostasis occurs?

3.4

Contribution and Capacity ofMitochondrial Calcium Uptake with Advancing Age
3.4.1

Blockade of mitochondria. Mitochondria are important organelles in the

control of [Ca2+]i-transients as they have been shown to buffer [Ca2+]i loads within the
normal physiological range and in the absence of pathology (Werth & Thayer, 1994;
Buchholz et al., 1996; David, Barrett & Barrett, 1998; Pinton et al, 1998; Rizzuto et al.
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1998). Previous studies have demonstrated an increased reliance on mitochondrial
calcium uptake in neurons from aged compared to young animals. Addition of the
mitochondrial calcium uptake blocker dinitrophenol (DNP) depressed the recovery phase
after high [K ]-evoked [Ca ]i-transients to a greater extent in acutely dissociated SCG
neurons from old compared to young rats (Table 1; Buchholz et al., 1996). Similarly,
exposure to DNP of tail arteries from aged animals caused an increase in stimulationevoked norepinephrine release. In contrast, DNP had no significant effect on
norepinephrine release in young arteries (Table 1; Tsai, Duckies & Buchholz, 1995).
Together these studies suggest that mitochondrial calcium uptake in peripheral neurons
may become more important functionally with advancing age.
3.4.2 Reliance on mitochondria. To complement this study we wished to
determine if calcium buffering capacity changed with age when SCG cells were forced to
rely solely on mitochondria to regulate [Ca2+]i-transients. Young and aged SCG cells
were forced to rely on mitochondria by blocking the contributions of both PMC A and
I

^j

SERCA with vanadate (100 pM), as well as by blocking Na /Ca -exchange by
replacement of [Na+]e with TEA (Pottorf et al, 2000b). Interestingly, in the presence of
these blockers both young and aged SCG cells were still able to recover from [K+]evoked [Ca ]i-transients. Furthermore, there was no difference in the extent of this
recovery with age (Table 1; Pottorf et al, 2000b). These data and the previous study
suggest that when multiple calcium buffering systems are blocked, mitochondria are still
able to restore [Ca2+]i-transients to basal levels in adrenergic nerves, and this ability is
maintained in nerves from older animals.
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Effects ofAge on Plasma Membrane Calcium Transport Systems

3.5

Along with mitochondria, additional components of the calcium buffering system
could also compensate for a decline in calcium regulation with advancing age. Recent
evidence has highlighted the role of the PMCAs as important participants in the dynamic
regulation of [Ca2+]i-transients and as crucial players in calcium extrusion during normal
(Carafoli & Stauffer, 1994; Werth, Usachev & Thayer, 1996) and pathological conditions
(Garcia & Strehler, 1999). Additionally, Na /Ca -exchange is an important component
2_|_

of [Ca ]i regulation that interconnects both sodium and calcium homeostasis in neuronal
cells (Blaustein & Lederer, 1999).
3.5.1

Blockade of mitochondria and SERCAs. In rat adrenergic neurons, when

mitochondrial calcium uptake and SERCAs are blocked with DNP and thapsigargin,
respectively, SCG cells are “forced” to rely on plasma membrane calcium extrusion
systems (PMCAs and Na+/Ca2+-exchange) to control high [K+]-evoked [Ca2+]i-transients
(Tsai et al., 1998). Under these conditions SCG cells from both old and young animals
were able to fully recover from high [K ]-evoked [Ca ]i-transients. While the rate of
recovery in neurons from young rats was unchanged by this treatment, there was an
increase in the rate of recovery in aged neurons (Table 1; Tsai et al., 1998). These data
94-

suggest that plasmalemmal calcium extrusion alone can effectively control [Ca ]itransients and that there is an induction of remaining calcium buffering components (i.e.
I

21

•

•

PMCA and Na /Ca -exchanger) during advancing age.
3.5.2 Blockade ofPMCAs and SERCAs. The ability of Ca2+-ATPase pumps in
plasma membranes and ER (PMCA and SERCA, respectively) to control [K+]-evoked
94-

[Ca ]i-transients was also assessed with advancing age in SCG cells (Pottorf et al,
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2000b). Blockade of PMC A function with a relatively low concentration of vanadate
(0.1 |iM), which does not significantly affect the function of SERCAs, induced a greater
decline in the rate of recovery of [Ca ]i in SCO cells from old compared to young
animals (Table 1; Pottorf et al, 2000b). Increasing the vanadate concentration to 1.0 pM,
which can block both PMCAs and SERCAs, did not produce a further effect on the rate
of recovery of [Ca2d" ]i in old SCG cells; however, there was a further decline in calcium
recovery in cells from young animals (Table 1; Pottorf et al, 2000b). Therefore, the
differential effect of vanadate on Ca -ATPase pumps revealed a biphasic effect on rate
of recovery of [Ca2+]i in young SCG cells compared to only a single phase response in
cells from old animals. These data suggest that PMCA function is maintained with age;
furthermore, the plasma membrane extrusion system can apparently provide some
compensatory buffering capacity for this age-related deficit in SERCA function. Studies
in SCG cells suggest that the calcium buffering system has several redundant
mechanisms that allow for compensation when one or more components are
compromised. Therefore, with advancing age, when SERCA function is attenuated, the
remaining calcium buffering components become a critical part of maintaining calcium
homeostasis and preventing calcium overload in adrenergic neurons.
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DIFFERENTIAL EFFECT OF AGE ON RESPONSE TO PHARMACOLOGICAL
MANIPULATION AFFECTING INTRACELLULAR CALCIUM BUFFERING

[Ca2+]i-Transient
Rate of Recovery
(SCG)

Treatment

Stimulation-Evoked
Norepinephrine Release
(RTA)

Young

Aged

Young

Aged

n/d

n/d

I

u

Enhanced Calcium Buffering
BAPTA (100 pM)(5)
Blockade of Buffering Components
SERCA

(cyclopiazonic acid)(6)

Mitochondria

(dinitrophenol)

(1,4)

I

T

U

n/d

SERCA & Mitochondria
(thapsigargin + dinitrophenol)(6)

I

PMCA

u

(low vanadate)(2)

PMCA & SERCA

n/d

u
u

n/d

n/d

t

n/d

n/d

I

u

n/d

n/d

u

u

n/d

n/d

(high vanadate)(2)

t

Reliance on Single Buffering Component
Reliance on SERCA
(vanadate + dinitrophenol + zero Na+)

(3)

Reliance on Mitochondria
(vanadate + zero Na+)(2)

Table 1. The following symbols represent changes from control values: (T) increase from control; (l)
decrease from control; (—) no change from control; and (n/d) no data available. BAPTA, l,2-bis(2aminophenoxy)ethane-AZ N,N’,N ’-tetraacetatic acid. Fisher-344 rats were used for all experiments and
divided into two age groups of young (6 month) and aged (20 month). [Ca2+]i-transients were recorded by
microfluorometry using fura-2 in acutely dissociated rat superior cervical ganglion (SCG) cells, and rate
of recovery of [Ca2+]i (nM/sec) compared to control within each age group. Electrical stimulation-evoked
norepinephrine release was measured in rat tail arteries (RTA) and compared to control values within each
age group. Norepinephrine was collected from isolated arteries during and after electric field stimulation,
and samples analyzed by HPLC with electrochemical detection.
1.
2.
3.
4.
5.
6.

Buchholz, J., Tsai, H., Foucart, S. & Duckies, S.P. (1996). Neurobiol. Aging, 17, 885-92.
Pottorf, W.J., Duckies, S.P. & Buchholz, J.N. (2000b). J. Auton. Pharm., in press.
Pottorf, W.J., Duckies, S.P. & Buchholz, J.N. (2000c). J. Auton. Pharm., submitted.
Tsai, H., Duckies, S.P. & Buchholz, J. (1995). Neurobiol. Aging, 16,111-1.
Tsai, H., Hewitt, C.W., Buchholz, J.N. & Duckies, S.P. (1997). Neurobiol. Aging, 18, 229-33.
Tsai, H., Pottorf, W.J., Buchholz, J.N. & Duckies, S.P. (1998). Neurobiol. Aging, 19, 89-96.
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3.6

Comparison of the Effects of Age on Function and Expression of SERCA in Rat
Cerebral Cortex
Thus far studies in SCG cells and tail arteries have provided evidence for

functional declines in SERCA activity and an induction of compensatory mechanisms by
alternate calcium buffering components with advancing age. The molecular regulation of
this calcium pumps has been identified and quantified in neuronal and several other
tissues; however, no comparison of SERCA expression with advancing age has been
studied. Studies measuring 45Ca2+-uptake by microsomes isolated from dorsal root
ganglion cells and skeletal muscle also have shown declines in SERCA function with
advancing age (Gafni & Yuh, 1989; Kirischuk & Verkhratsky, 1996). However, the
mechanism of an age-related reduction in SERCA function has, as yet, to be resolved.
Investigators have struggled to explain age-related changes in SERCA function and
mRNA expression without corresponding changes in protein levels. Age-related declines
in SERCA function have been supported with similar reductions in mRNA expression in
cardiac tissue and vascular smooth muscle (Maciel et al, 1990; Lompre, 1999).
However, the expression of SERCA proteins in the same tissues does not show
corresponding changes in protein levels with advancing age (Ferrington et al, 1997; Xu
& Narayanan, 1998). Therefore, further studies are necessary to answer the question of
age-related changes in SERCA expression and the connection with declines in SERCA
function.
We sought to answer functional changes in SERCA activity with changes in
molecular regulation of SERCA expression and protein levels in young (6 month) and old
(20 month) Fisher-344 (F-344) rat cerebral cortex. Functional studies were conducted by
using ATP-dependent, oxalate-facilitated 45Ca2+-uptake into microsomes isolated from rat
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cerebral cortex and comparing the two age groups. From this same tissue model, agerelated functional changes in SERCA activity were compared with changes in mRNA
expression and protein levels of the SERCA3 isoform.
3.6.1

45 Ca2+-uptake into microsomal and plasma membrane vesicle fractions.

The focus of this study was to investigate the impact of age on calcium uptake into two
subcellular fractions of microsomes and plasma membrane vesicles (PMV) in the
presence and absence of the selective SERCA blocker thapsigargin (Pottorf et al., 2000a).
The two subcellular fractions isolated from young and old rat cerebral cortex revealed
increasing 45Ca2+-uptake with incubation time; however, there was no difference with
advancing age (Table 2; Pottorf et al, 2000a). In the presence of thapsigargin (0.1 pM)
ATP-dependent, oxalate-facilitated 45Ca2+-uptake into microsomes was significantly
declined in both age groups compared to control values. Whereas, PMV fractions
exposed to even higher concentrations of thapsigargin (5 pM) had no significant effect on
45Ca2+-uptake compared to control values for either age group (Table 2; Pottorf et al.
2000a). The lack of effect of thapsigargin in PMV fractions suggests that isolated PMVs
from rat cerebral cortex are primarily enriched with PMCAs and that SERCA
contamination is not a major factor. Conversely, the higher sensitivity to thapsigargin
blockade observed in mircrosome fractions suggests that this subcellular fraction contains
a higher content of SERCAs compared to PMV fractions. Although an age-related
change in calcium uptake was not observed in microsomes isolated from rat cerebral
cortex, our functional studies in superior cervical ganglion (SCG) cells suggest such a
decline in SERCA activity does exists (Table 1). Calcium uptake by microsomes isolated
from skeletal muscle and dorsal root ganglion cells has shown declines in SERCA
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function with advancing age (Gafhi & Yuh, 1989; Kirischuk & Verkhratsky, 1996).
However, the opposite effect of increased calcium uptake has been shown in rat brain
microsomes (Hanahisa & Yamaguchi, 1998; Yamaguchi et al., 1999). This discrepancy
between studies measuring calcium uptake by microsomes in brain, dorsal root ganglion,
or skeletal muscle suggests that a clear mechanism for age-related changes still need
further clarification. Additionally, our microfluorometric studies with SCG cells suggest
a significant decline in the ability of SERCAs to control [Ca2+]i-transients and maintain
calcium homeostasis with advancing age (Table 1; Tsai et al, 1998; Pottorf et al., 2000b;
2000c). Contrasting studies, with respect to calcium buffering in central and peripheral
neurons, underscore the need for caution in suggesting a universal mechanism causing
age-related changes in SERCA function. It may indeed be that age-related declines in
SERCA function are restricted to peripheral excitable tissues and that SERCA function in
these tissues is more sensitive to aging than that of central neurons.
3.6.2

SERCAS mRNA expression and protein content. Molecular regulation of

the SERCA3 isoform was examined in rat cerebral cortex from young and aged animals.
Comparison of SERCA3 mRNA expression demonstrated a significant decline in the
transcript with advancing age (Table 2; Pottorf et al, 2000a). Our investigation of the
literature revealed no other studies that have attempted to determine levels of SERCA
mRNA expression with advancing age in neuronal tissue. However, there are a few
studies that have investigated age-related changes in SERCA expression in rat cardiac
tissue and vascular smooth muscle (Maciel et al, 1990; Lompre, 1999). Our study
correlates well with these studies that revealed a significant decline in the mRNA
expression of SERCAs with advancing age.
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To verify age-related declines in SERCA3 mRNA expression, we measured
protein levels of the same isoform in rat cerebral cortex. SERCA3 protein levels were
shown to remain stable with advancing age (Table 2; Pottorf et al., 2000a). Therefore, an
age-related decline in SERCA3 mRNA expression did not coincide with a parallel
decrease in protein levels. However, this same phenomenon has also been observed in rat
skeletal muscle and myocardium (Ferrington et al, 1997; Xu & Narayanan, 1998). In
these studies, measurement of SERCA protein levels also did not show a corresponding
age-related change as predicted from measurements of mRNA expression in the same
tissues. These studies investigating molecular changes of SERCAs suggest that a downregulation in SERCA mRNA expression does not necessarily result in a parallel shift in
SERCA protein levels with advancing age.

SUMMARY OF FUNCTIONAL AND MOLECULAR STUDIES IN RAT CEREBRAL CORTEX

Young

Study

Aged

i

Effect of TG on 45Ca2+-Uptake in Microsomes
Effect of TG on 45Ca2+-Uptake in PMV
SERCA3 mRNA Expression (compared to young)

F

SERCA3 Protein Levels (compared to young)

Table 2. The following symbols represent changes from control values: (T) increase from control and
(—) no change from control. Cerebral cortex from Fisher-344 rats were used for all experiments and
divided into two age groups of young (6 month) and aged (20 month). 45Ca2+-uptake studies in
microsomes (enriched with SERCA) and plasma membrane vesicles (PMV, enriched with PMCA) were
exposed to the selective SERCA blocker thapsigargin (TG) and compared to control (absence of TG)
within each age group. SERCA3 mRNA expression was determined by Northern blot analysis and
compared with cyclophilin as an internal control. SERCA3 protein levels were determined by Western
blot analysis. Functional and molecular data reported in this table represents a previous study submitted
for publication (Pottorf et al, 2000a).
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4.

CONCLUSIONS & FINAL THOUGHTS
There were two hypotheses proposed at the beginning of this dissertation

concerning possible mechanisms of dysregulation of [Ca ]i homeostasis with advancing
age (page 22-24). First, a permanent change in the regulation of neuronal calcium may
occur with advancing age leading to neurodegeneration. Second, instead of permanent
9-1-

neuronal loss, subtle changes in [Ca ]i homeostasis may occur leading to altered
neuronal performance. However, in this case functional compensation by remaining
9_i_

calcium buffering components may be effective in controlling [Ca ]i-transients and
preventing calcium overload. In this model, functional consequences of age-related
changes may be subtle because of effective cellular compensation.
The evidence presented in this dissertation supports the second hypothesis in the
case of peripheral adrenergic neurons. These studies document a significant reduction in
the function of SERCA pumps to control [Ca2+]i-transients with advancing age in SCG
cells and tail artery adrenergic nerves. However, multiple calcium buffering components
such as PMCA, mitochondria, and Na+/Ca2+-exchange are also present, and these can
functionally compensate for a deficit by another buffering component. Thus, our
governing hypothesis is conserved stating that in peripheral adrenergic nerves calcium
uptake by ATP-dependent calcium buffering components of the endoplasmic reticulum is
reduced with advancing age, leading to greater or more sustained [Ca ]i levels, a greater
reliance on remaining calcium buffering components to restore [Ca ]i homeostasis and
increased neurotransmitter release (page 24; representative graph of governing hypothesis
refer to Fig 2, page 26).
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It is important to understand that the aging process is complex and multifaceted.
The hypothesis proposed is just one of many possible theories that attempt to define and
understand the role of [Ca2+]i regulation and aging in neurons. Despite our knowledge of
the mechanisms involved in neuronal [Ca2+]i regulation, elucidation of the importance,
participation, and regulation of each calcium buffering component is still lacking, and
additional studies are necessary to confirm their respective roles in normal aging of
neurons, both in the peripheral and central nervous systems.

‘No wise man ever wished to be younger. ’
Swift (1667-1745).
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APPENDIX I:
SERCA CALCIUM TRANSPORT AND MOLECULAR STRUCTURE

Reaction Cycle for Calcium Transport by SERCA
The sarco/endoplasmic reticulum calcium ATPase (SERCA) pump is an integral
membrane protein and a member of the P-type ATPases. The SERCA pump transports
two calcium ions against a concentration gradient into the organelle from the hydrolysis
of ATP (Fig 1). The E2 state exposes the high-affinity calcium-binding site, which binds
two calcium ions forming the E\ conformation state. After calcium binding, the SERCA
enzyme is phosphorylated by ATP at specific residue within the catalytic domain forming
the high-energy phosphoenzyme intermediate (EiP). The phosphoenzyme intermediate
undergoes a conformational change in the SERCA structure, producing the low-affinity
calcium binding state E^P, which expels the calcium ions into the lumen. Hydrolysis of
the phosphate group regenerates the high-affinity calcium binding state (£2) and resets
the enzyme for the next cycle.

3-Dimensional Molecular Modeling of SERCA1
The crystal structure of the calcium ATPase of skeletal muscle (SERCA1) has
been resolved at 2.6 A obtained by X-ray crystallography (Fig. 2). The SERCA crystals
were prepared in lipid membranes forming planar stacks and grown in the presence of 10
mM CaCU The SERCA enzyme is primarily composed of four major domains: 1.
Actuator domain (pink and green); 2. Catalytic domain (dark blue); 3. ATP-binding and
hinge domain (red); and 4. Membrane and stalk domain (light blue). The two calcium
ions (purple) are located side-by-side and are surrounded by ten transmembrane a-helices
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forming the stalk and membrane domain. The four transmembrane domains of M4, M5,
M6, and M8 are clustered within the membrane domain and form the two calcium
binding sites. The cytoplasmic region consists of three major domains, with the ATP
phosphorylation site at Asp351 residue (yellow) located within the catalytic domain. The
adenosine-binding and hinge domain stabilizes the ATP molecule and forms the main
head region. The actuator domain is formed between the M2 and M3 helices of the
membrane domain.
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Figure 1. Conformational states of SERCAs. There are at least four interconvertible
conformations that have been identified during the cycle of ATP-dependent calcium transport.
(a) Increases in [Ca2+]i saturates the two high-affinity calcium binding sites to form the Ei state.
(b) The enzyme then binds ATP forming a high-energy phosphoenzyme intermediate (ffiP). (c)
The rate-limiting step results in a conformational change leading to a low-affinity calcium state,
E2P, and release of the calcium ions into the lumen, (d) The enzyme then undergoes hydrolysis to
remove the phosphate group regenerating the E2 state.
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Figure 2. Molecular structure of the SERCA1 enzyme at a resolution of 2.6 A obtained by X-ray
crystallography. The molecular structure of SERCA1 can be divided into 4 main domains. The
SERCA enzyme is primarily composed of four major domains: (1) Actuator domain (pink and
green); (2) Catalytic domain (dark blue); (3) ATP-binding and hinge domain (red); and (4)
Membrane and stalk domain (light blue). The four ct-helices of the membrane domain M4, M5,
M6, and M8 form the two calcium-binding sites. The ATP phosphorylation site at Asp351 residue
(yellow) if located within the catalytic domain. The actuator domain is formed between M2 and
M3 a-helices of the membrane domain. Inset, shows the bottom view of the membrane domain
from the lumenal face. The four membrane regions (M4, M5, M6, M8) are clustered around the
calcium ions to form the two calcium-binding sites.
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